HRI
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00264 | S57 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFtPAE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O60841 | S190 | Sugiyama | EIF5B IF2 KIAA0741 | NsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGP |
| O60841 | S222 | Sugiyama | EIF5B IF2 KIAA0741 | KNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAEKKERERKK |
| O60927 | S73 | Sugiyama | PPP1R11 HCGV TCTE5 | MGRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRG |
| O60927 | S74 | Sugiyama | PPP1R11 HCGV TCTE5 | GRRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGH |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95394 | S64 | Sugiyama | PGM3 AGM1 | LLAVLRSKQTKSTIGVMVtAsHNPEEDNGVKLVDPLGEMLA |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S114 | Sugiyama | ALPP PLAP | DRFPYVALSKTYNVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P05198 | S49 | GPS6|SIGNOR|ELM|EPSD|PSP | EIF2S1 EIF2A | EMGAYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNE |
| P05198 | S52 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | EIF2S1 EIF2A | AYVSLLEYNNIEGMILLsELsRRRIRSINKLIRIGRNECVV |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09923 | S111 | Sugiyama | ALPI | DRFPYLALSKTYNVDRQVPDsAATATAYLCGVKANFQTIGL |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P10696 | S111 | Sugiyama | ALPG ALPPL ALPPL2 | DRFPYVALSKTYSVDKHVPDsGAtATAYLCGVKGNFQTIGL |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P23396 | T220 | Sugiyama | RPS3 OK/SW-cl.26 | PKKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPV |
| P23396 | T221 | Sugiyama | RPS3 OK/SW-cl.26 | KKPLPDHVsIVEPKDEILPttPIsEQKGGKPEPPAMPQPVP |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27816 | T521 | Sugiyama | MAP4 | GLLKDMsPLsEtEMALGKDVtPPPEtEVVLIKNVCLPPEME |
| P27816 | T526 | Sugiyama | MAP4 | MsPLsEtEMALGKDVtPPPEtEVVLIKNVCLPPEMEVALTE |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1713 | Sugiyama | MYH9 | ERAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQ |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1155 | Sugiyama | MYH9 | RDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKKT |
| P42677 | S11 | Sugiyama | RPS27 MPS1 | __________MPLAKDLLHPsPEEEKRKHKKKRLVQsPNsy |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P60484 | T382 | Sugiyama | PTEN MMAC1 TEP1 | sTSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItK |
| P60484 | T383 | Sugiyama | PTEN MMAC1 TEP1 | TSVtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | S80 | Sugiyama | RCN1 RCN | HEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGDGFVt |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q99676 | T167 | Sugiyama | ZNF184 | EGSLERQQANQQTLPKEIKVtEKTIPSWEKGPVNNEFGKSV |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BQI3 | S144 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | ITHLMRSAKERVRQDPCEDIsRIQKIRsREVALEAQTSRYL |
| Q9BQI3 | S151 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | AKERVRQDPCEDIsRIQKIRsREVALEAQTSRYLNEFEELA |
| Q9BQI3 | S253 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | WIEHVHVIQPRADRAAIELPsLEVLsDQEEDREQCGVKNDE |
| Q9BQI3 | S258 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | HVIQPRADRAAIELPsLEVLsDQEEDREQCGVKNDEsssss |
| Q9BQI3 | S409 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | LSLWDWIVERNKRGREyVDEsACPYVMANVATKIFQELVEG |
| Q9BQI3 | Y405 | Sugiyama | EIF2AK1 HRI KIAA1369 PRO1362 | QLCELSLWDWIVERNKRGREyVDEsACPYVMANVATKIFQE |
| Q9BRS2 | T509 | Sugiyama | RIOK1 RIO1 | QVEERtCsDsEDIGssECsDtDSEEQGDHARPKKHTTDPDI |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9UPR0 | T584 | Sugiyama | PLCL2 KIAA1092 PLCE2 | KILIKAKKLsSNCSGVEGDVtDEDEGAEMSQRMGKENMEQP |
| Q9UQ35 | T856 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFEss |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 9.500178e-13 | 12.022 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.746614e-11 | 10.241 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.319680e-10 | 9.635 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.409022e-09 | 8.851 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.709107e-09 | 8.767 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.361330e-08 | 7.133 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.174755e-08 | 7.088 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.165646e-07 | 6.933 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.165646e-07 | 6.933 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.467380e-07 | 6.833 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.528904e-07 | 6.344 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.261848e-07 | 6.279 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.484288e-07 | 6.188 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.429069e-07 | 6.129 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.223505e-06 | 5.912 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.223505e-06 | 5.912 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.067929e-06 | 5.971 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.078682e-06 | 5.967 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.124070e-06 | 5.949 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.244959e-06 | 5.905 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.040852e-06 | 5.983 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.809637e-06 | 5.742 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.101671e-06 | 5.508 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.494768e-06 | 5.347 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.567661e-06 | 5.340 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.259159e-06 | 5.279 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.259159e-06 | 5.279 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.083669e-06 | 5.294 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.150619e-06 | 5.146 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.150619e-06 | 5.146 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.150619e-06 | 5.146 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 7.055404e-06 | 5.151 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.925063e-06 | 5.003 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.528494e-06 | 5.021 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 9.434284e-06 | 5.025 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.925063e-06 | 5.003 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.348852e-05 | 4.870 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.348852e-05 | 4.870 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.524103e-05 | 4.817 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.779845e-05 | 4.750 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.668633e-05 | 4.778 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.590918e-05 | 4.798 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.689751e-05 | 4.772 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.765390e-05 | 4.753 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.026564e-05 | 4.693 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.572186e-05 | 4.590 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.579339e-05 | 4.588 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.663257e-05 | 4.575 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.916564e-05 | 4.535 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.029671e-05 | 4.519 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.053049e-05 | 4.515 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.343661e-05 | 4.476 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.350576e-05 | 4.475 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.613679e-05 | 4.442 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.799118e-05 | 4.420 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.939341e-05 | 4.405 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.101427e-05 | 4.387 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.630206e-05 | 4.334 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.808053e-05 | 4.318 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.580869e-05 | 4.253 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.240401e-05 | 4.205 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.240401e-05 | 4.205 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.122592e-05 | 4.213 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.384128e-05 | 4.195 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.515323e-05 | 4.186 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.691833e-05 | 4.174 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.026629e-05 | 4.095 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 7.775691e-05 | 4.109 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.649227e-05 | 4.063 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.001440e-04 | 3.999 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.001440e-04 | 3.999 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.021530e-04 | 3.991 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.072298e-04 | 3.970 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.108730e-04 | 3.955 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.210357e-04 | 3.917 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.315420e-04 | 3.881 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.315420e-04 | 3.881 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.315420e-04 | 3.881 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.315420e-04 | 3.881 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.749405e-04 | 3.757 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.749405e-04 | 3.757 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.749405e-04 | 3.757 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.749405e-04 | 3.757 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.920302e-04 | 3.717 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.970543e-04 | 3.705 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.144713e-04 | 3.669 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.338254e-04 | 3.631 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.357060e-04 | 3.628 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.659827e-04 | 3.575 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.659827e-04 | 3.575 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.557324e-04 | 3.592 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 2.733946e-04 | 3.563 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.924260e-04 | 3.534 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.983875e-04 | 3.525 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.059577e-04 | 3.514 | 1 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.183709e-04 | 3.497 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.282151e-04 | 3.484 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.544860e-04 | 3.450 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.801772e-04 | 3.420 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.854307e-04 | 3.414 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.919143e-04 | 3.407 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.249736e-04 | 3.372 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.455151e-04 | 3.351 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.553094e-04 | 3.342 | 1 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.601624e-04 | 3.337 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.065531e-04 | 3.295 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.473707e-04 | 3.262 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.745236e-04 | 3.241 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.745236e-04 | 3.241 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.933324e-04 | 3.227 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.933324e-04 | 3.227 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.536998e-04 | 3.185 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.598480e-04 | 3.181 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.776984e-04 | 3.169 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.777095e-04 | 3.169 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.777095e-04 | 3.169 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 8.846687e-04 | 3.053 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.846687e-04 | 3.053 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.263621e-04 | 3.083 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 8.846687e-04 | 3.053 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 8.583128e-04 | 3.066 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.443851e-04 | 3.073 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.443851e-04 | 3.073 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 8.938131e-04 | 3.049 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.013215e-04 | 3.045 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.581233e-04 | 3.019 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.581233e-04 | 3.019 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.008639e-03 | 2.996 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 1.101652e-03 | 2.958 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 1.101652e-03 | 2.958 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.033269e-03 | 2.986 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.074369e-03 | 2.969 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.111281e-03 | 2.954 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.220063e-03 | 2.914 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.220063e-03 | 2.914 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.220063e-03 | 2.914 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.265047e-03 | 2.898 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 1.363985e-03 | 2.865 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.405610e-03 | 2.852 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.405610e-03 | 2.852 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.405610e-03 | 2.852 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.363985e-03 | 2.865 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.326026e-03 | 2.877 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.318526e-03 | 2.880 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.369980e-03 | 2.863 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.422443e-03 | 2.847 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.422443e-03 | 2.847 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.438487e-03 | 2.842 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.520551e-03 | 2.818 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.586703e-03 | 2.800 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.673003e-03 | 2.777 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.683503e-03 | 2.774 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.720286e-03 | 2.764 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.887088e-03 | 2.724 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.834394e-03 | 2.737 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.799965e-03 | 2.745 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.940927e-03 | 2.712 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.890268e-03 | 2.723 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.948375e-03 | 2.710 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.083213e-03 | 2.681 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.332982e-03 | 2.632 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 2.451007e-03 | 2.611 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.451007e-03 | 2.611 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.451333e-03 | 2.611 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.547334e-03 | 2.594 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.722567e-03 | 2.565 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.755625e-03 | 2.560 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.755625e-03 | 2.560 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 2.844075e-03 | 2.546 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.849225e-03 | 2.545 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.849454e-03 | 2.545 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.980198e-03 | 2.526 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.167933e-03 | 2.499 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.150702e-03 | 2.502 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.369417e-03 | 2.472 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.272575e-03 | 2.485 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.481896e-03 | 2.458 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.523398e-03 | 2.453 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.667932e-03 | 2.436 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.944943e-03 | 2.404 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.047917e-03 | 2.393 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.077994e-03 | 2.390 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.107087e-03 | 2.386 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.107087e-03 | 2.386 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.226874e-03 | 2.374 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.226874e-03 | 2.374 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.608486e-03 | 2.336 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.608486e-03 | 2.336 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.610759e-03 | 2.336 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.661958e-03 | 2.331 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.900224e-03 | 2.310 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.918674e-03 | 2.308 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.196070e-03 | 2.284 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.676336e-03 | 2.246 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.957529e-03 | 2.225 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.000520e-03 | 2.222 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.000520e-03 | 2.222 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.091200e-03 | 2.215 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.091200e-03 | 2.215 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.091200e-03 | 2.215 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.481440e-03 | 2.261 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.117801e-03 | 2.213 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.176224e-03 | 2.209 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.301905e-03 | 2.201 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.543928e-03 | 2.184 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.687335e-03 | 2.175 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.295612e-03 | 2.137 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.311139e-03 | 2.136 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.631997e-03 | 2.117 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.878304e-03 | 2.104 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 8.122245e-03 | 2.090 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 8.122245e-03 | 2.090 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.122245e-03 | 2.090 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.221453e-03 | 2.085 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.336214e-03 | 2.079 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 8.867354e-03 | 2.052 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 8.867354e-03 | 2.052 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.547854e-03 | 2.020 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.978210e-03 | 2.047 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.000519e-02 | 2.000 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.000519e-02 | 2.000 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.895353e-03 | 2.005 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.585331e-03 | 2.018 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 1.000519e-02 | 2.000 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.573095e-03 | 2.019 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.128538e-03 | 2.040 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.978210e-03 | 2.047 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.051182e-02 | 1.978 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.098139e-02 | 1.959 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.108446e-02 | 1.955 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.150481e-02 | 1.939 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.150481e-02 | 1.939 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.157405e-02 | 1.937 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.157405e-02 | 1.937 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.157405e-02 | 1.937 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.222178e-02 | 1.913 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.257945e-02 | 1.900 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.267223e-02 | 1.897 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.267223e-02 | 1.897 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.267223e-02 | 1.897 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.267223e-02 | 1.897 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.307551e-02 | 1.884 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.307551e-02 | 1.884 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.307551e-02 | 1.884 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.362005e-02 | 1.866 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.367412e-02 | 1.864 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.378115e-02 | 1.861 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.419706e-02 | 1.848 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.419706e-02 | 1.848 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.419706e-02 | 1.848 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.419706e-02 | 1.848 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.464261e-02 | 1.834 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.476817e-02 | 1.831 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.530675e-02 | 1.815 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.530675e-02 | 1.815 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.623197e-02 | 1.790 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.727647e-02 | 1.763 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.975951e-02 | 1.704 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.976493e-02 | 1.704 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.803773e-02 | 1.744 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.786425e-02 | 1.748 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.979895e-02 | 1.703 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.727647e-02 | 1.763 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.765354e-02 | 1.753 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.847431e-02 | 1.733 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.011950e-02 | 1.696 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.025781e-02 | 1.693 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.123336e-02 | 1.673 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.160087e-02 | 1.666 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.269518e-02 | 1.644 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.269518e-02 | 1.644 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.269518e-02 | 1.644 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.278752e-02 | 1.642 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.372506e-02 | 1.625 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.410536e-02 | 1.618 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.410536e-02 | 1.618 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.410536e-02 | 1.618 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.427457e-02 | 1.615 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.427457e-02 | 1.615 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.427457e-02 | 1.615 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 2.427457e-02 | 1.615 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 2.427457e-02 | 1.615 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.427457e-02 | 1.615 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.427457e-02 | 1.615 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.427457e-02 | 1.615 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.433615e-02 | 1.614 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.445405e-02 | 1.612 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.457713e-02 | 1.609 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.508089e-02 | 1.601 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.570940e-02 | 1.590 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.813949e-02 | 1.551 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.757712e-02 | 1.559 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.209051e-02 | 1.494 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.794582e-02 | 1.554 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.794582e-02 | 1.554 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.784351e-02 | 1.555 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.646663e-02 | 1.577 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.588791e-02 | 1.587 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.813949e-02 | 1.551 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.989391e-02 | 1.524 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.947326e-02 | 1.531 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.615782e-02 | 1.582 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.680186e-02 | 1.572 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.650769e-02 | 1.577 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 2.893212e-02 | 1.539 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.231860e-02 | 1.491 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.209051e-02 | 1.494 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.116224e-02 | 1.506 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.041830e-02 | 1.517 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.761688e-02 | 1.559 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.886515e-02 | 1.540 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.757712e-02 | 1.559 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.152985e-02 | 1.501 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.127948e-02 | 1.505 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.323002e-02 | 1.478 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.383493e-02 | 1.471 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.519199e-02 | 1.454 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.532082e-02 | 1.452 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.598135e-02 | 1.444 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 3.648668e-02 | 1.438 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.736858e-02 | 1.427 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.819578e-02 | 1.418 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.819578e-02 | 1.418 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.821734e-02 | 1.418 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.834363e-02 | 1.416 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.852749e-02 | 1.414 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.856611e-02 | 1.414 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.982842e-02 | 1.400 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.982842e-02 | 1.400 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.055069e-02 | 1.392 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.175556e-02 | 1.379 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.200169e-02 | 1.377 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.206232e-02 | 1.376 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.206232e-02 | 1.376 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.244553e-02 | 1.372 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.307954e-02 | 1.366 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.369912e-02 | 1.360 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.382873e-02 | 1.358 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 4.414052e-02 | 1.355 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.436450e-02 | 1.353 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.551222e-02 | 1.342 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.616651e-02 | 1.336 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.819562e-02 | 1.317 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.928358e-02 | 1.307 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.957206e-02 | 1.305 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.957206e-02 | 1.305 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 4.957206e-02 | 1.305 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.040092e-02 | 1.298 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.040092e-02 | 1.298 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.040092e-02 | 1.298 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.040092e-02 | 1.298 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.042294e-02 | 1.297 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.055309e-02 | 1.296 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.055309e-02 | 1.296 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 5.055309e-02 | 1.296 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 5.055309e-02 | 1.296 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.055309e-02 | 1.296 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.055309e-02 | 1.296 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.139871e-02 | 1.289 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.245323e-02 | 1.280 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.245323e-02 | 1.280 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.323719e-02 | 1.274 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.323719e-02 | 1.274 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.370014e-02 | 1.270 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.402207e-02 | 1.267 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.492424e-02 | 1.260 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.492424e-02 | 1.260 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.492424e-02 | 1.260 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.492424e-02 | 1.260 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.509735e-02 | 1.259 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.702751e-02 | 1.244 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.712190e-02 | 1.243 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.712190e-02 | 1.243 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 5.787571e-02 | 1.238 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 5.787571e-02 | 1.238 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.948032e-02 | 1.226 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.967625e-02 | 1.224 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.990529e-02 | 1.223 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.992717e-02 | 1.222 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.059724e-02 | 1.218 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.173623e-02 | 1.209 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 6.182810e-02 | 1.209 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.182810e-02 | 1.209 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.621870e-02 | 1.179 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.621870e-02 | 1.179 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.269959e-02 | 1.082 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.500098e-02 | 1.187 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.500098e-02 | 1.187 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.500098e-02 | 1.187 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.952618e-02 | 1.099 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.952618e-02 | 1.099 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 7.952618e-02 | 1.099 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.192194e-02 | 1.143 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.269959e-02 | 1.082 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 6.532540e-02 | 1.185 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 6.621870e-02 | 1.179 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.429821e-02 | 1.192 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.836969e-02 | 1.165 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.108464e-02 | 1.091 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.447870e-02 | 1.128 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.272691e-02 | 1.138 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 8.325170e-02 | 1.080 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.325170e-02 | 1.080 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 8.325170e-02 | 1.080 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 8.325170e-02 | 1.080 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.325170e-02 | 1.080 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 8.375627e-02 | 1.077 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.474183e-02 | 1.072 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.524324e-02 | 1.069 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.632030e-02 | 1.064 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.646221e-02 | 1.063 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.646221e-02 | 1.063 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.646221e-02 | 1.063 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.772667e-02 | 1.057 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 8.865826e-02 | 1.052 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.931996e-02 | 1.049 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.968092e-02 | 1.047 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.193237e-02 | 1.037 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.370383e-02 | 1.028 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.398746e-02 | 1.027 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.400810e-02 | 1.027 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.400810e-02 | 1.027 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.400810e-02 | 1.027 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.400810e-02 | 1.027 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 9.412298e-02 | 1.026 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.738026e-02 | 1.012 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.738026e-02 | 1.012 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.738026e-02 | 1.012 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.002174e-01 | 0.999 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.012451e-01 | 0.995 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 1.014417e-01 | 0.994 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 1.014417e-01 | 0.994 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 1.014417e-01 | 0.994 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 1.014417e-01 | 0.994 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.014417e-01 | 0.994 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.061518e-01 | 0.974 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.061518e-01 | 0.974 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.067125e-01 | 0.972 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.069488e-01 | 0.971 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.083191e-01 | 0.965 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.124051e-01 | 0.949 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.124051e-01 | 0.949 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.124051e-01 | 0.949 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 1.124051e-01 | 0.949 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.124051e-01 | 0.949 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.124051e-01 | 0.949 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.124051e-01 | 0.949 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.124051e-01 | 0.949 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.124051e-01 | 0.949 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.637815e-01 | 0.786 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.637815e-01 | 0.786 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.637815e-01 | 0.786 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 1.637815e-01 | 0.786 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.637815e-01 | 0.786 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.637815e-01 | 0.786 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.637815e-01 | 0.786 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.637815e-01 | 0.786 | 0 | 0 |
| Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-5619099 | 1.637815e-01 | 0.786 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.205981e-01 | 0.919 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.205981e-01 | 0.919 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.405482e-01 | 0.852 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.405482e-01 | 0.852 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.405482e-01 | 0.852 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.405482e-01 | 0.852 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.405482e-01 | 0.852 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.611364e-01 | 0.793 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.611364e-01 | 0.793 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.187443e-01 | 0.925 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.187443e-01 | 0.925 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.187443e-01 | 0.925 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.594723e-01 | 0.797 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 1.475841e-01 | 0.831 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.255956e-01 | 0.901 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.523565e-01 | 0.817 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.523565e-01 | 0.817 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.523626e-01 | 0.817 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.605930e-01 | 0.794 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.487111e-01 | 0.828 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.284953e-01 | 0.891 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.421136e-01 | 0.847 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.264338e-01 | 0.898 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.187443e-01 | 0.925 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.205981e-01 | 0.919 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 1.611364e-01 | 0.793 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 1.431842e-01 | 0.844 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 1.405482e-01 | 0.852 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.318575e-01 | 0.880 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.368428e-01 | 0.864 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.501914e-01 | 0.823 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.268945e-01 | 0.897 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.288619e-01 | 0.890 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.187443e-01 | 0.925 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.611364e-01 | 0.793 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.098861e-01 | 0.959 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.159249e-01 | 0.936 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.159249e-01 | 0.936 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.159249e-01 | 0.936 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.159249e-01 | 0.936 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.611364e-01 | 0.793 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.617669e-01 | 0.791 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.611364e-01 | 0.793 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.611364e-01 | 0.793 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.523565e-01 | 0.817 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.104379e-01 | 0.957 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.254463e-01 | 0.902 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.586387e-01 | 0.800 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.155918e-01 | 0.937 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.243226e-01 | 0.905 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.611364e-01 | 0.793 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.475841e-01 | 0.831 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.274696e-01 | 0.895 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.460924e-01 | 0.835 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.207480e-01 | 0.918 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.597716e-01 | 0.797 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 1.405482e-01 | 0.852 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.159249e-01 | 0.936 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.523626e-01 | 0.817 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.171989e-01 | 0.931 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.227917e-01 | 0.911 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.290325e-01 | 0.889 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.611364e-01 | 0.793 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.375743e-01 | 0.861 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 1.637815e-01 | 0.786 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.205981e-01 | 0.919 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 1.368428e-01 | 0.864 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.523565e-01 | 0.817 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.431842e-01 | 0.844 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.475841e-01 | 0.831 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.205981e-01 | 0.919 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.611364e-01 | 0.793 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.530244e-01 | 0.815 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.586387e-01 | 0.800 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.611364e-01 | 0.793 | 1 | 1 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.245386e-01 | 0.905 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.460924e-01 | 0.835 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.163755e-01 | 0.934 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.657955e-01 | 0.780 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.679426e-01 | 0.775 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 1.695372e-01 | 0.771 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.699870e-01 | 0.770 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.699870e-01 | 0.770 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.699870e-01 | 0.770 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.714045e-01 | 0.766 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.737326e-01 | 0.760 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.738871e-01 | 0.760 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.738871e-01 | 0.760 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.738871e-01 | 0.760 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.784600e-01 | 0.748 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 1.803796e-01 | 0.744 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.805258e-01 | 0.743 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.812579e-01 | 0.742 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.812579e-01 | 0.742 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.816091e-01 | 0.741 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.816091e-01 | 0.741 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.816091e-01 | 0.741 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.822222e-01 | 0.739 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.822222e-01 | 0.739 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 1.822222e-01 | 0.739 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.822222e-01 | 0.739 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.822222e-01 | 0.739 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.822222e-01 | 0.739 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.882023e-01 | 0.725 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.882023e-01 | 0.725 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.885677e-01 | 0.725 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.886495e-01 | 0.724 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.886495e-01 | 0.724 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.886495e-01 | 0.724 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.886495e-01 | 0.724 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.886495e-01 | 0.724 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.886495e-01 | 0.724 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.886495e-01 | 0.724 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.886495e-01 | 0.724 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 2.121870e-01 | 0.673 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 2.121870e-01 | 0.673 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 2.121870e-01 | 0.673 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.121870e-01 | 0.673 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.577932e-01 | 0.589 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.577932e-01 | 0.589 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.577932e-01 | 0.589 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 2.577932e-01 | 0.589 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.577932e-01 | 0.589 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 3.007619e-01 | 0.522 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 3.007619e-01 | 0.522 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 3.007619e-01 | 0.522 | 0 | 0 |
| Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate | R-HSA-2978092 | 3.007619e-01 | 0.522 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 3.007619e-01 | 0.522 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.007619e-01 | 0.522 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 3.412455e-01 | 0.467 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 3.412455e-01 | 0.467 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.412455e-01 | 0.467 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.412455e-01 | 0.467 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 3.412455e-01 | 0.467 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.253938e-01 | 0.647 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.253938e-01 | 0.647 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.253938e-01 | 0.647 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.472647e-01 | 0.607 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.472647e-01 | 0.607 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.472647e-01 | 0.607 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.472647e-01 | 0.607 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.472647e-01 | 0.607 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.472647e-01 | 0.607 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.911220e-01 | 0.536 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.911220e-01 | 0.536 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 2.346078e-01 | 0.630 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.346078e-01 | 0.630 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.129561e-01 | 0.505 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.129561e-01 | 0.505 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.129561e-01 | 0.505 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.503517e-01 | 0.601 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.503517e-01 | 0.601 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.055936e-01 | 0.687 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.055936e-01 | 0.687 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.179151e-01 | 0.662 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.179151e-01 | 0.662 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.822521e-01 | 0.549 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.431150e-01 | 0.614 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.983391e-01 | 0.525 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.044075e-01 | 0.690 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.689232e-01 | 0.570 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.689232e-01 | 0.570 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.144738e-01 | 0.502 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.773411e-01 | 0.423 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.136495e-01 | 0.670 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.136495e-01 | 0.670 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.306257e-01 | 0.481 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.306257e-01 | 0.481 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.951828e-01 | 0.530 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.951828e-01 | 0.530 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.084346e-01 | 0.511 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.084346e-01 | 0.511 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.350916e-01 | 0.475 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.350916e-01 | 0.475 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.350916e-01 | 0.475 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.818177e-01 | 0.550 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 3.618389e-01 | 0.441 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 3.350863e-01 | 0.475 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.749176e-01 | 0.426 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.936236e-01 | 0.713 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.671810e-01 | 0.573 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.089251e-01 | 0.680 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.007028e-01 | 0.522 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.888709e-01 | 0.539 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.692010e-01 | 0.570 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.467660e-01 | 0.460 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.113282e-01 | 0.507 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 3.700443e-01 | 0.432 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.669281e-01 | 0.435 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.350863e-01 | 0.475 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.107182e-01 | 0.676 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.217433e-01 | 0.492 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.926906e-01 | 0.534 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.951659e-01 | 0.530 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.084346e-01 | 0.511 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.084346e-01 | 0.511 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.107182e-01 | 0.676 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.333472e-01 | 0.632 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.331203e-01 | 0.477 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.331203e-01 | 0.477 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.552713e-01 | 0.593 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.692010e-01 | 0.570 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.253938e-01 | 0.647 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.472647e-01 | 0.607 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.559530e-01 | 0.592 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.951828e-01 | 0.530 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.179151e-01 | 0.662 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.234876e-01 | 0.490 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 3.007619e-01 | 0.522 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.412455e-01 | 0.467 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.472647e-01 | 0.607 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.692010e-01 | 0.570 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.055936e-01 | 0.687 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.561179e-01 | 0.448 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.773411e-01 | 0.423 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.503517e-01 | 0.601 | 1 | 1 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.561179e-01 | 0.448 | 0 | 0 |
| Translation | R-HSA-72766 | 2.926399e-01 | 0.534 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.129561e-01 | 0.505 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.559530e-01 | 0.592 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.762237e-01 | 0.559 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.132476e-01 | 0.504 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.036791e-01 | 0.691 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.692010e-01 | 0.570 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 3.129561e-01 | 0.505 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.346400e-01 | 0.475 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.773411e-01 | 0.423 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.217433e-01 | 0.492 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.005619e-01 | 0.698 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 3.007619e-01 | 0.522 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.911220e-01 | 0.536 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 3.773411e-01 | 0.423 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.962810e-01 | 0.707 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.628674e-01 | 0.440 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.004393e-01 | 0.522 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.055936e-01 | 0.687 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.773411e-01 | 0.423 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.084346e-01 | 0.511 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 3.093272e-01 | 0.510 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.644379e-01 | 0.438 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.822521e-01 | 0.549 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 2.121870e-01 | 0.673 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.577932e-01 | 0.589 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.007619e-01 | 0.522 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.412455e-01 | 0.467 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.472647e-01 | 0.607 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.692010e-01 | 0.570 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 2.911220e-01 | 0.536 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 2.911220e-01 | 0.536 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 2.911220e-01 | 0.536 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.346078e-01 | 0.630 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.561179e-01 | 0.448 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.325481e-01 | 0.633 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 3.350916e-01 | 0.475 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.421832e-01 | 0.616 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.367169e-01 | 0.626 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.539731e-01 | 0.451 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.796006e-01 | 0.553 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 3.484622e-01 | 0.458 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.435313e-01 | 0.464 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.431150e-01 | 0.614 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.421878e-01 | 0.616 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.262063e-01 | 0.645 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.147415e-01 | 0.668 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.129561e-01 | 0.505 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.129561e-01 | 0.505 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.179151e-01 | 0.662 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 3.561179e-01 | 0.448 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.055936e-01 | 0.687 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.385716e-01 | 0.622 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.975331e-01 | 0.704 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.586582e-01 | 0.587 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.325481e-01 | 0.633 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 3.346400e-01 | 0.475 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.079804e-01 | 0.511 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.435313e-01 | 0.464 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.200598e-01 | 0.657 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.422426e-01 | 0.466 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.472647e-01 | 0.607 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.822521e-01 | 0.549 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.492002e-01 | 0.603 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.822521e-01 | 0.549 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.822521e-01 | 0.549 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 2.565948e-01 | 0.591 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.415013e-01 | 0.617 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.620497e-01 | 0.582 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.577932e-01 | 0.589 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.577932e-01 | 0.589 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.007619e-01 | 0.522 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 3.007619e-01 | 0.522 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 2.036791e-01 | 0.691 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 3.412455e-01 | 0.467 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.412455e-01 | 0.467 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.346078e-01 | 0.630 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.561179e-01 | 0.448 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.743178e-01 | 0.562 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.346078e-01 | 0.630 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.346078e-01 | 0.630 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.773411e-01 | 0.423 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.583756e-01 | 0.446 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.606754e-01 | 0.584 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.539731e-01 | 0.451 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.036791e-01 | 0.691 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.911220e-01 | 0.536 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.304291e-01 | 0.637 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.350863e-01 | 0.475 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.637560e-01 | 0.439 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.517953e-01 | 0.599 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.588662e-01 | 0.587 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.435313e-01 | 0.464 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.503517e-01 | 0.601 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.951828e-01 | 0.530 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.473673e-01 | 0.607 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.482089e-01 | 0.605 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.577932e-01 | 0.589 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 3.007619e-01 | 0.522 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 3.007619e-01 | 0.522 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.412455e-01 | 0.467 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 3.412455e-01 | 0.467 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.412455e-01 | 0.467 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.253938e-01 | 0.647 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.692010e-01 | 0.570 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.346400e-01 | 0.475 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.951828e-01 | 0.530 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.084346e-01 | 0.511 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.519433e-01 | 0.599 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.217433e-01 | 0.492 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.204192e-01 | 0.657 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.350863e-01 | 0.475 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 3.749176e-01 | 0.426 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.513539e-01 | 0.600 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.393676e-01 | 0.469 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 2.367169e-01 | 0.626 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 2.230325e-01 | 0.652 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.346078e-01 | 0.630 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.079804e-01 | 0.511 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.822521e-01 | 0.549 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 3.412455e-01 | 0.467 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.253938e-01 | 0.647 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.561179e-01 | 0.448 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.773411e-01 | 0.423 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.820062e-01 | 0.550 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.519433e-01 | 0.599 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.253938e-01 | 0.647 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.503517e-01 | 0.601 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.951828e-01 | 0.530 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 2.664169e-01 | 0.574 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.036791e-01 | 0.691 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 2.911220e-01 | 0.536 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.039238e-01 | 0.691 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.983391e-01 | 0.525 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.953147e-01 | 0.709 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 2.472647e-01 | 0.607 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.890131e-01 | 0.539 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.817611e-01 | 0.550 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 3.412455e-01 | 0.467 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.467660e-01 | 0.460 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.641635e-01 | 0.439 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.304291e-01 | 0.637 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.692010e-01 | 0.570 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.726670e-01 | 0.564 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.503517e-01 | 0.601 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.789045e-01 | 0.421 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.789045e-01 | 0.421 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 3.793874e-01 | 0.421 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.793874e-01 | 0.421 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.793874e-01 | 0.421 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.793874e-01 | 0.421 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.793874e-01 | 0.421 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.793874e-01 | 0.421 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.793874e-01 | 0.421 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 3.793874e-01 | 0.421 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.793874e-01 | 0.421 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.793874e-01 | 0.421 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.793874e-01 | 0.421 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 3.793874e-01 | 0.421 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.793874e-01 | 0.421 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 3.793874e-01 | 0.421 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.793874e-01 | 0.421 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 3.793874e-01 | 0.421 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.793874e-01 | 0.421 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.797428e-01 | 0.421 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.885478e-01 | 0.411 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.885478e-01 | 0.411 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.885478e-01 | 0.411 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.885478e-01 | 0.411 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.885478e-01 | 0.411 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.885478e-01 | 0.411 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.885478e-01 | 0.411 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.885478e-01 | 0.411 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.889477e-01 | 0.410 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.933765e-01 | 0.405 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.933765e-01 | 0.405 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.948536e-01 | 0.404 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.948536e-01 | 0.404 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.971188e-01 | 0.401 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.982671e-01 | 0.400 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.982671e-01 | 0.400 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.982671e-01 | 0.400 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.982671e-01 | 0.400 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 3.982671e-01 | 0.400 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 3.982671e-01 | 0.400 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.982671e-01 | 0.400 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 3.982671e-01 | 0.400 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.982671e-01 | 0.400 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.018505e-01 | 0.396 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.018505e-01 | 0.396 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.018505e-01 | 0.396 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.018505e-01 | 0.396 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.050199e-01 | 0.393 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.050199e-01 | 0.393 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.063702e-01 | 0.391 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.106924e-01 | 0.386 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.106924e-01 | 0.386 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.106924e-01 | 0.386 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.131268e-01 | 0.384 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.142065e-01 | 0.383 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.150999e-01 | 0.382 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.153232e-01 | 0.382 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.153232e-01 | 0.382 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 4.153232e-01 | 0.382 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 4.153232e-01 | 0.382 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 4.153232e-01 | 0.382 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 4.153232e-01 | 0.382 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 4.153232e-01 | 0.382 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.153232e-01 | 0.382 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.153232e-01 | 0.382 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 4.153232e-01 | 0.382 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.153232e-01 | 0.382 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 4.153232e-01 | 0.382 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.153902e-01 | 0.382 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 4.166351e-01 | 0.380 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 4.188593e-01 | 0.378 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 4.188593e-01 | 0.378 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.188593e-01 | 0.378 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.188593e-01 | 0.378 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.188593e-01 | 0.378 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.189116e-01 | 0.378 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.264006e-01 | 0.370 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.282129e-01 | 0.368 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.282830e-01 | 0.368 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.290730e-01 | 0.367 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.354705e-01 | 0.361 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.376901e-01 | 0.359 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 4.390862e-01 | 0.357 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 4.390862e-01 | 0.357 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.390862e-01 | 0.357 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.390862e-01 | 0.357 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 4.390862e-01 | 0.357 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.390862e-01 | 0.357 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 4.397442e-01 | 0.357 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.413872e-01 | 0.355 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.413872e-01 | 0.355 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.419592e-01 | 0.355 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.419592e-01 | 0.355 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.419592e-01 | 0.355 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.436780e-01 | 0.353 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.463393e-01 | 0.350 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.488726e-01 | 0.348 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.491801e-01 | 0.348 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 4.491801e-01 | 0.348 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.491801e-01 | 0.348 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 4.491801e-01 | 0.348 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 4.491801e-01 | 0.348 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.491801e-01 | 0.348 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 4.491801e-01 | 0.348 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.491801e-01 | 0.348 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.491801e-01 | 0.348 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.545288e-01 | 0.342 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.563426e-01 | 0.341 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.573507e-01 | 0.340 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.573507e-01 | 0.340 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.589210e-01 | 0.338 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 4.589210e-01 | 0.338 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.589210e-01 | 0.338 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.589210e-01 | 0.338 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 4.589210e-01 | 0.338 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.597720e-01 | 0.337 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.601094e-01 | 0.337 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.601094e-01 | 0.337 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.601094e-01 | 0.337 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.640105e-01 | 0.333 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.673124e-01 | 0.330 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.673124e-01 | 0.330 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.673124e-01 | 0.330 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 4.712404e-01 | 0.327 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.725592e-01 | 0.326 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.725592e-01 | 0.326 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.725592e-01 | 0.326 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.734469e-01 | 0.325 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.739760e-01 | 0.324 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.739760e-01 | 0.324 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.783414e-01 | 0.320 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 4.783414e-01 | 0.320 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.783414e-01 | 0.320 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 4.783414e-01 | 0.320 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.789291e-01 | 0.320 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.801118e-01 | 0.319 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.801118e-01 | 0.319 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.801118e-01 | 0.319 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.801118e-01 | 0.319 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 4.810784e-01 | 0.318 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.810784e-01 | 0.318 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 4.810784e-01 | 0.318 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.810784e-01 | 0.318 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.810784e-01 | 0.318 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.810784e-01 | 0.318 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 4.810784e-01 | 0.318 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.810784e-01 | 0.318 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.810784e-01 | 0.318 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.810784e-01 | 0.318 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.810784e-01 | 0.318 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.810784e-01 | 0.318 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.810784e-01 | 0.318 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 4.810784e-01 | 0.318 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.810784e-01 | 0.318 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.810784e-01 | 0.318 | 0 | 0 |
| RSK activation | R-HSA-444257 | 4.810784e-01 | 0.318 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.810784e-01 | 0.318 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.828551e-01 | 0.316 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.843984e-01 | 0.315 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.852395e-01 | 0.314 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 4.875702e-01 | 0.312 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.875702e-01 | 0.312 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.912952e-01 | 0.309 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.922087e-01 | 0.308 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.927890e-01 | 0.307 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.927890e-01 | 0.307 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.927890e-01 | 0.307 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.964172e-01 | 0.304 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 4.973290e-01 | 0.303 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.973290e-01 | 0.303 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.973290e-01 | 0.303 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 4.973290e-01 | 0.303 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.973290e-01 | 0.303 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.992157e-01 | 0.302 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.992157e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.023706e-01 | 0.299 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.023706e-01 | 0.299 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.053350e-01 | 0.296 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.075025e-01 | 0.295 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 5.111313e-01 | 0.291 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 5.111313e-01 | 0.291 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.111313e-01 | 0.291 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 5.111313e-01 | 0.291 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.111313e-01 | 0.291 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 5.111313e-01 | 0.291 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 5.111313e-01 | 0.291 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.111313e-01 | 0.291 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.111313e-01 | 0.291 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 5.111313e-01 | 0.291 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 5.111313e-01 | 0.291 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 5.111313e-01 | 0.291 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.158686e-01 | 0.287 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.169484e-01 | 0.287 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.177412e-01 | 0.286 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.177412e-01 | 0.286 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.184889e-01 | 0.285 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.205834e-01 | 0.284 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.292036e-01 | 0.276 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.299996e-01 | 0.276 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.299996e-01 | 0.276 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.312932e-01 | 0.275 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.312932e-01 | 0.275 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.312932e-01 | 0.275 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.339485e-01 | 0.273 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.339485e-01 | 0.273 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 5.339485e-01 | 0.273 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.339485e-01 | 0.273 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.339485e-01 | 0.273 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.371685e-01 | 0.270 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 5.394454e-01 | 0.268 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.394454e-01 | 0.268 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 5.394454e-01 | 0.268 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.394454e-01 | 0.268 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.394454e-01 | 0.268 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.394454e-01 | 0.268 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 5.394454e-01 | 0.268 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.394454e-01 | 0.268 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.394454e-01 | 0.268 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 5.398584e-01 | 0.268 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 5.453955e-01 | 0.263 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.453955e-01 | 0.263 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.474672e-01 | 0.262 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.507958e-01 | 0.259 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 5.515599e-01 | 0.258 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.515599e-01 | 0.258 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 5.515599e-01 | 0.258 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 5.515599e-01 | 0.258 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 5.515599e-01 | 0.258 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.515599e-01 | 0.258 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.515599e-01 | 0.258 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.515599e-01 | 0.258 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 5.515599e-01 | 0.258 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.540447e-01 | 0.256 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.592472e-01 | 0.252 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.592472e-01 | 0.252 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.592472e-01 | 0.252 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.613295e-01 | 0.251 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.648442e-01 | 0.248 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.658185e-01 | 0.247 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.661212e-01 | 0.247 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.661212e-01 | 0.247 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.661212e-01 | 0.247 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.661212e-01 | 0.247 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 5.661212e-01 | 0.247 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.661212e-01 | 0.247 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.661212e-01 | 0.247 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.661212e-01 | 0.247 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.661212e-01 | 0.247 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.661212e-01 | 0.247 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 5.661212e-01 | 0.247 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.661212e-01 | 0.247 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.661212e-01 | 0.247 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.661212e-01 | 0.247 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.686962e-01 | 0.245 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.686962e-01 | 0.245 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 5.686962e-01 | 0.245 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.686962e-01 | 0.245 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 5.686962e-01 | 0.245 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.708358e-01 | 0.243 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.728410e-01 | 0.242 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 5.735947e-01 | 0.241 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.742367e-01 | 0.241 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 5.774189e-01 | 0.239 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.820160e-01 | 0.235 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.820160e-01 | 0.235 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.843277e-01 | 0.233 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.853535e-01 | 0.233 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.853535e-01 | 0.233 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.853535e-01 | 0.233 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.861707e-01 | 0.232 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.861707e-01 | 0.232 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.888410e-01 | 0.230 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.912535e-01 | 0.228 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.912535e-01 | 0.228 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.912535e-01 | 0.228 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.912535e-01 | 0.228 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.912535e-01 | 0.228 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 5.912535e-01 | 0.228 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.912535e-01 | 0.228 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 5.912535e-01 | 0.228 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.912535e-01 | 0.228 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.912535e-01 | 0.228 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.912535e-01 | 0.228 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.912535e-01 | 0.228 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.912535e-01 | 0.228 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.921604e-01 | 0.228 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.931738e-01 | 0.227 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.931738e-01 | 0.227 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.990560e-01 | 0.223 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.992314e-01 | 0.222 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.000801e-01 | 0.222 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.000801e-01 | 0.222 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.015298e-01 | 0.221 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.120186e-01 | 0.213 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.120186e-01 | 0.213 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.149314e-01 | 0.211 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.149314e-01 | 0.211 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.149314e-01 | 0.211 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.149314e-01 | 0.211 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.149314e-01 | 0.211 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 6.149314e-01 | 0.211 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 6.149314e-01 | 0.211 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.149314e-01 | 0.211 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.149314e-01 | 0.211 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 6.149314e-01 | 0.211 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 6.149314e-01 | 0.211 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.149314e-01 | 0.211 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 6.149314e-01 | 0.211 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 6.149314e-01 | 0.211 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.149314e-01 | 0.211 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.149314e-01 | 0.211 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.149314e-01 | 0.211 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 6.149314e-01 | 0.211 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.149314e-01 | 0.211 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.169469e-01 | 0.210 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.172248e-01 | 0.210 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.172248e-01 | 0.210 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.196985e-01 | 0.208 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.219942e-01 | 0.206 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.293327e-01 | 0.201 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.313310e-01 | 0.200 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.314332e-01 | 0.200 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.314332e-01 | 0.200 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 6.323565e-01 | 0.199 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.324401e-01 | 0.199 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.324401e-01 | 0.199 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.324401e-01 | 0.199 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.324401e-01 | 0.199 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.367599e-01 | 0.196 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 6.372390e-01 | 0.196 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 6.372390e-01 | 0.196 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 6.372390e-01 | 0.196 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 6.372390e-01 | 0.196 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.372390e-01 | 0.196 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.372390e-01 | 0.196 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.372390e-01 | 0.196 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.372390e-01 | 0.196 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.471785e-01 | 0.189 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.471785e-01 | 0.189 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 6.471785e-01 | 0.189 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.485098e-01 | 0.188 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.560190e-01 | 0.183 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.582556e-01 | 0.182 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.582556e-01 | 0.182 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.582556e-01 | 0.182 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.582556e-01 | 0.182 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.582556e-01 | 0.182 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.582556e-01 | 0.182 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 6.582556e-01 | 0.182 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.582556e-01 | 0.182 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.614161e-01 | 0.180 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.614443e-01 | 0.180 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.637836e-01 | 0.178 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.637836e-01 | 0.178 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.685368e-01 | 0.175 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.752427e-01 | 0.171 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.752427e-01 | 0.171 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.780558e-01 | 0.169 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.780558e-01 | 0.169 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.780558e-01 | 0.169 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.780558e-01 | 0.169 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.780558e-01 | 0.169 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 6.780558e-01 | 0.169 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.780558e-01 | 0.169 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.780558e-01 | 0.169 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.780558e-01 | 0.169 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 6.780558e-01 | 0.169 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.780558e-01 | 0.169 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.780558e-01 | 0.169 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.780558e-01 | 0.169 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.828624e-01 | 0.166 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.830285e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.847483e-01 | 0.164 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.885799e-01 | 0.162 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.885799e-01 | 0.162 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.885799e-01 | 0.162 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.885799e-01 | 0.162 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.912686e-01 | 0.160 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.924968e-01 | 0.160 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.936817e-01 | 0.159 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.936817e-01 | 0.159 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.936817e-01 | 0.159 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.967099e-01 | 0.157 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.967099e-01 | 0.157 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.967099e-01 | 0.157 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.967099e-01 | 0.157 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.967099e-01 | 0.157 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.967099e-01 | 0.157 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.967099e-01 | 0.157 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.967099e-01 | 0.157 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.967099e-01 | 0.157 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.967099e-01 | 0.157 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.967099e-01 | 0.157 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.970265e-01 | 0.157 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.980370e-01 | 0.156 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.013757e-01 | 0.154 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.014631e-01 | 0.154 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.014631e-01 | 0.154 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.014631e-01 | 0.154 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.014631e-01 | 0.154 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.014631e-01 | 0.154 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.014631e-01 | 0.154 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.014631e-01 | 0.154 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.014631e-01 | 0.154 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.042199e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.055756e-01 | 0.151 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 7.106020e-01 | 0.148 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.139000e-01 | 0.146 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 7.139000e-01 | 0.146 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.142842e-01 | 0.146 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 7.142842e-01 | 0.146 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 7.142842e-01 | 0.146 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 7.142842e-01 | 0.146 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.142842e-01 | 0.146 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 7.142842e-01 | 0.146 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 7.142842e-01 | 0.146 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 7.142842e-01 | 0.146 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.142842e-01 | 0.146 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.142842e-01 | 0.146 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.142842e-01 | 0.146 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.142842e-01 | 0.146 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.142842e-01 | 0.146 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.142842e-01 | 0.146 | 0 | 0 |
| Formation of xylulose-5-phosphate | R-HSA-5661270 | 7.142842e-01 | 0.146 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 7.142842e-01 | 0.146 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.195030e-01 | 0.143 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.258992e-01 | 0.139 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.258992e-01 | 0.139 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.258992e-01 | 0.139 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.282084e-01 | 0.138 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.282084e-01 | 0.138 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.282084e-01 | 0.138 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 7.308412e-01 | 0.136 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 7.308412e-01 | 0.136 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 7.308412e-01 | 0.136 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.308412e-01 | 0.136 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.308412e-01 | 0.136 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.338307e-01 | 0.134 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.338307e-01 | 0.134 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.341821e-01 | 0.134 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.367966e-01 | 0.133 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.374696e-01 | 0.132 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.374696e-01 | 0.132 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.374696e-01 | 0.132 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.374696e-01 | 0.132 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 7.436021e-01 | 0.129 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.464396e-01 | 0.127 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.464396e-01 | 0.127 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.464396e-01 | 0.127 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.464396e-01 | 0.127 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 7.486206e-01 | 0.126 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 7.531091e-01 | 0.123 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.531091e-01 | 0.123 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.531091e-01 | 0.123 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 7.593618e-01 | 0.120 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.593618e-01 | 0.120 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.593618e-01 | 0.120 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.611350e-01 | 0.119 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.611350e-01 | 0.119 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.611350e-01 | 0.119 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.611350e-01 | 0.119 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.611350e-01 | 0.119 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.611350e-01 | 0.119 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.611350e-01 | 0.119 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.611350e-01 | 0.119 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 7.611350e-01 | 0.119 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 7.616691e-01 | 0.118 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.629589e-01 | 0.117 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.634017e-01 | 0.117 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.697034e-01 | 0.114 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 7.697034e-01 | 0.114 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 7.697034e-01 | 0.114 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.697034e-01 | 0.114 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 7.730456e-01 | 0.112 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.749795e-01 | 0.111 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.749795e-01 | 0.111 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.749795e-01 | 0.111 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.749795e-01 | 0.111 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.770722e-01 | 0.110 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.770722e-01 | 0.110 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.770722e-01 | 0.110 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.778943e-01 | 0.109 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.796555e-01 | 0.108 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.796555e-01 | 0.108 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.880223e-01 | 0.103 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.880223e-01 | 0.103 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.880223e-01 | 0.103 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.880223e-01 | 0.103 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.880223e-01 | 0.103 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.880223e-01 | 0.103 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.880223e-01 | 0.103 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.880223e-01 | 0.103 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.880223e-01 | 0.103 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 7.880223e-01 | 0.103 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.892285e-01 | 0.103 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.892285e-01 | 0.103 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.892285e-01 | 0.103 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.901278e-01 | 0.102 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.964285e-01 | 0.099 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.973718e-01 | 0.098 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.984330e-01 | 0.098 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.984330e-01 | 0.098 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.984330e-01 | 0.098 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.984330e-01 | 0.098 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.984330e-01 | 0.098 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 8.003100e-01 | 0.097 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 8.003100e-01 | 0.097 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.003100e-01 | 0.097 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.003100e-01 | 0.097 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 8.003100e-01 | 0.097 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.003100e-01 | 0.097 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.033107e-01 | 0.095 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.033107e-01 | 0.095 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.040893e-01 | 0.095 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.072794e-01 | 0.093 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.106249e-01 | 0.091 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.118860e-01 | 0.091 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.118860e-01 | 0.091 | 0 | 0 |
| Free fatty acid receptors | R-HSA-444209 | 8.118860e-01 | 0.091 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.118860e-01 | 0.091 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.118860e-01 | 0.091 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 8.118860e-01 | 0.091 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.118860e-01 | 0.091 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.157783e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.195988e-01 | 0.086 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.195988e-01 | 0.086 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.201532e-01 | 0.086 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.201532e-01 | 0.086 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 8.227916e-01 | 0.085 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.227916e-01 | 0.085 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.227916e-01 | 0.085 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.227916e-01 | 0.085 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.227916e-01 | 0.085 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.227916e-01 | 0.085 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.238172e-01 | 0.084 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 8.239403e-01 | 0.084 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 8.239403e-01 | 0.084 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 8.239403e-01 | 0.084 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.239403e-01 | 0.084 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.298525e-01 | 0.081 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.305217e-01 | 0.081 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.317759e-01 | 0.080 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.317759e-01 | 0.080 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.317759e-01 | 0.080 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.330657e-01 | 0.079 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.330657e-01 | 0.079 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.330657e-01 | 0.079 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.330657e-01 | 0.079 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.330657e-01 | 0.079 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.350038e-01 | 0.078 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.392954e-01 | 0.076 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.392954e-01 | 0.076 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 8.396351e-01 | 0.076 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.396521e-01 | 0.076 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.416000e-01 | 0.075 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.427446e-01 | 0.074 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.427446e-01 | 0.074 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.427446e-01 | 0.074 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.427446e-01 | 0.074 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.432752e-01 | 0.074 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.432752e-01 | 0.074 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.466205e-01 | 0.072 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.466205e-01 | 0.072 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.493344e-01 | 0.071 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 8.518629e-01 | 0.070 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.518629e-01 | 0.070 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.518629e-01 | 0.070 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.518629e-01 | 0.070 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.518629e-01 | 0.070 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.518629e-01 | 0.070 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.518629e-01 | 0.070 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.534273e-01 | 0.069 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.600599e-01 | 0.065 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.604530e-01 | 0.065 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.604530e-01 | 0.065 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.604530e-01 | 0.065 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.604530e-01 | 0.065 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.604530e-01 | 0.065 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.604530e-01 | 0.065 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.604530e-01 | 0.065 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.608973e-01 | 0.065 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.617340e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.645062e-01 | 0.063 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.654020e-01 | 0.063 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.654020e-01 | 0.063 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.663029e-01 | 0.062 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 8.664167e-01 | 0.062 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.664167e-01 | 0.062 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.664167e-01 | 0.062 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.685455e-01 | 0.061 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.685455e-01 | 0.061 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.685455e-01 | 0.061 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.685455e-01 | 0.061 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.685455e-01 | 0.061 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 8.715730e-01 | 0.060 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.715730e-01 | 0.060 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.761691e-01 | 0.057 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.761691e-01 | 0.057 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 8.761691e-01 | 0.057 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.781850e-01 | 0.056 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.783416e-01 | 0.056 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 8.787829e-01 | 0.056 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.794364e-01 | 0.056 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.829476e-01 | 0.054 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.833511e-01 | 0.054 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.833511e-01 | 0.054 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.833511e-01 | 0.054 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.833511e-01 | 0.054 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.833511e-01 | 0.054 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.833511e-01 | 0.054 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.862965e-01 | 0.052 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.899197e-01 | 0.051 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.901169e-01 | 0.051 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.901169e-01 | 0.051 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.901169e-01 | 0.051 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.943957e-01 | 0.048 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.943957e-01 | 0.048 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.964907e-01 | 0.047 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.964907e-01 | 0.047 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 8.992939e-01 | 0.046 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.022632e-01 | 0.045 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.024951e-01 | 0.045 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.024951e-01 | 0.045 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.024951e-01 | 0.045 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.024951e-01 | 0.045 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.039795e-01 | 0.044 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.081516e-01 | 0.042 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.081516e-01 | 0.042 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.084609e-01 | 0.042 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.084609e-01 | 0.042 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.127458e-01 | 0.040 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 9.127458e-01 | 0.040 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.127458e-01 | 0.040 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.134802e-01 | 0.039 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.134802e-01 | 0.039 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.134802e-01 | 0.039 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.134802e-01 | 0.039 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.134802e-01 | 0.039 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.144930e-01 | 0.039 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.168421e-01 | 0.038 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.168421e-01 | 0.038 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.168421e-01 | 0.038 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.181514e-01 | 0.037 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.185000e-01 | 0.037 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.185000e-01 | 0.037 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.198598e-01 | 0.036 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.214776e-01 | 0.036 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.232288e-01 | 0.035 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.232288e-01 | 0.035 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.232288e-01 | 0.035 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.232288e-01 | 0.035 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.237428e-01 | 0.034 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.276836e-01 | 0.033 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.276836e-01 | 0.033 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.276836e-01 | 0.033 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.280721e-01 | 0.032 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.318801e-01 | 0.031 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.318801e-01 | 0.031 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.318801e-01 | 0.031 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.318801e-01 | 0.031 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.318801e-01 | 0.031 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.321154e-01 | 0.031 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.328532e-01 | 0.030 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.347459e-01 | 0.029 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.358333e-01 | 0.029 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.378586e-01 | 0.028 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.395573e-01 | 0.027 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.395573e-01 | 0.027 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.408301e-01 | 0.026 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.430654e-01 | 0.025 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.430654e-01 | 0.025 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.430654e-01 | 0.025 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.430654e-01 | 0.025 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.445507e-01 | 0.025 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.453635e-01 | 0.024 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.453635e-01 | 0.024 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.463701e-01 | 0.024 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.463701e-01 | 0.024 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.463728e-01 | 0.024 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.464100e-01 | 0.024 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.468215e-01 | 0.024 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.469147e-01 | 0.024 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.485036e-01 | 0.023 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.489551e-01 | 0.023 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.491847e-01 | 0.023 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.494832e-01 | 0.023 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.494832e-01 | 0.023 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.509802e-01 | 0.022 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.514186e-01 | 0.022 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.524157e-01 | 0.021 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.524157e-01 | 0.021 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.524157e-01 | 0.021 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 9.551782e-01 | 0.020 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.551782e-01 | 0.020 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.551782e-01 | 0.020 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.577804e-01 | 0.019 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.577804e-01 | 0.019 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.581458e-01 | 0.019 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.602317e-01 | 0.018 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.602317e-01 | 0.018 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.602317e-01 | 0.018 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.602317e-01 | 0.018 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.625409e-01 | 0.017 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.633132e-01 | 0.016 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.643404e-01 | 0.016 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.647160e-01 | 0.016 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.647160e-01 | 0.016 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.647160e-01 | 0.016 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.705133e-01 | 0.013 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.715312e-01 | 0.013 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.716264e-01 | 0.013 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.719977e-01 | 0.012 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.733809e-01 | 0.012 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.737592e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.747688e-01 | 0.011 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.753589e-01 | 0.011 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.759522e-01 | 0.011 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.767904e-01 | 0.010 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.767904e-01 | 0.010 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.771460e-01 | 0.010 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.773338e-01 | 0.010 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.781168e-01 | 0.010 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.784565e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.813729e-01 | 0.008 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.813729e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.817323e-01 | 0.008 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.823048e-01 | 0.008 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.827938e-01 | 0.008 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.828154e-01 | 0.008 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.837937e-01 | 0.007 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.837937e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.840348e-01 | 0.007 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.843424e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.847356e-01 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.855999e-01 | 0.006 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.870156e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.882573e-01 | 0.005 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.886854e-01 | 0.005 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.891459e-01 | 0.005 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.891873e-01 | 0.005 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.891873e-01 | 0.005 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.893432e-01 | 0.005 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.899126e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.902200e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.902529e-01 | 0.004 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.904045e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.910962e-01 | 0.004 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.910962e-01 | 0.004 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.916139e-01 | 0.004 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.916139e-01 | 0.004 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.918761e-01 | 0.004 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.921016e-01 | 0.003 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.922733e-01 | 0.003 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.922926e-01 | 0.003 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.924417e-01 | 0.003 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.931740e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.937851e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.939082e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.951100e-01 | 0.002 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.951100e-01 | 0.002 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.951100e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.961207e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.962494e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.967861e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.969375e-01 | 0.001 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.973230e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.977576e-01 | 0.001 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.978027e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.983388e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.985218e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.985267e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.986733e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.989087e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.990322e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.990887e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.990965e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.992833e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.992863e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.995464e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.996189e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.997260e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.997967e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.998150e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.998201e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998644e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999015e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999072e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999085e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999353e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999609e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999657e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999870e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999936e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999943e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999954e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999988e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999998e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 4.949707e-12 | 11.305 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.005818e-12 | 11.097 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.011489e-10 | 9.995 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.357874e-09 | 8.627 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.745071e-09 | 8.561 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.885824e-08 | 7.724 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.885824e-08 | 7.724 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.810180e-08 | 7.167 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.810180e-08 | 7.167 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.132981e-08 | 7.212 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.132981e-08 | 7.212 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.469409e-07 | 6.607 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.825664e-07 | 6.549 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.420488e-07 | 6.466 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.292979e-07 | 6.201 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.404491e-07 | 6.194 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.892756e-07 | 6.103 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.334617e-07 | 6.079 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 8.704586e-07 | 6.060 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.005095e-06 | 5.998 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.243907e-06 | 5.905 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.767728e-06 | 5.753 | 1 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.354631e-06 | 5.628 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.998339e-06 | 5.523 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.446479e-06 | 5.463 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.160731e-06 | 5.381 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.515920e-06 | 5.345 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.112586e-06 | 5.291 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.610269e-06 | 5.251 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.730010e-06 | 5.242 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.606095e-06 | 5.180 | 1 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.112941e-06 | 5.148 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.741275e-06 | 5.111 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.440410e-05 | 4.842 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.360986e-05 | 4.866 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.402375e-05 | 4.853 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.441039e-05 | 4.841 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.518117e-05 | 4.819 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.730451e-05 | 4.762 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.241628e-05 | 4.649 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.208045e-05 | 4.656 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.154374e-05 | 4.667 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.736958e-05 | 4.563 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.350105e-05 | 4.475 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.704458e-05 | 4.431 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 3.819435e-05 | 4.418 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.312080e-05 | 4.365 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.312080e-05 | 4.365 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.555660e-05 | 4.341 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.592148e-05 | 4.338 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.292092e-05 | 4.276 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.458653e-05 | 4.263 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.192592e-05 | 4.208 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.360645e-05 | 4.078 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.789369e-05 | 4.056 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.655831e-05 | 4.063 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.633195e-05 | 4.016 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.119848e-04 | 3.951 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.145627e-04 | 3.941 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.174555e-04 | 3.930 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.228710e-04 | 3.911 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.321004e-04 | 3.879 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.321004e-04 | 3.879 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.588702e-04 | 3.799 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.721170e-04 | 3.764 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.678859e-04 | 3.775 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.861006e-04 | 3.730 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.861006e-04 | 3.730 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.892123e-04 | 3.723 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.095829e-04 | 3.679 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.217781e-04 | 3.654 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.217781e-04 | 3.654 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.393103e-04 | 3.621 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.411574e-04 | 3.618 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.971171e-04 | 3.527 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.152595e-04 | 3.501 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.279071e-04 | 3.484 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.296742e-04 | 3.482 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.050397e-04 | 3.393 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.338913e-04 | 3.363 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.494709e-04 | 3.347 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.467552e-04 | 3.350 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.517596e-04 | 3.345 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.733296e-04 | 3.325 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.765529e-04 | 3.322 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.392044e-04 | 3.268 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.231175e-04 | 3.281 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.231175e-04 | 3.281 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.116659e-04 | 3.291 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.553821e-04 | 3.255 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.590454e-04 | 3.181 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.050467e-04 | 3.043 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.576577e-04 | 3.067 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.777158e-04 | 3.057 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 9.135708e-04 | 3.039 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.164107e-04 | 3.038 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.422006e-04 | 3.026 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 9.713220e-04 | 3.013 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.101634e-03 | 2.958 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.112061e-03 | 2.954 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.048240e-03 | 2.980 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.050188e-03 | 2.979 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.141215e-03 | 2.943 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.227571e-03 | 2.911 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.366509e-03 | 2.864 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.398650e-03 | 2.854 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.398650e-03 | 2.854 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.398650e-03 | 2.854 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.398650e-03 | 2.854 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.366509e-03 | 2.864 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.398650e-03 | 2.854 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.505000e-03 | 2.822 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.652629e-03 | 2.782 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.667555e-03 | 2.778 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.755151e-03 | 2.756 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.755151e-03 | 2.756 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.763193e-03 | 2.754 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.845178e-03 | 2.734 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.854506e-03 | 2.732 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.021483e-03 | 2.694 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.092581e-03 | 2.679 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.105409e-03 | 2.677 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.305773e-03 | 2.637 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.435064e-03 | 2.613 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.234801e-03 | 2.651 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.278395e-03 | 2.642 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.435064e-03 | 2.613 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.376528e-03 | 2.624 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.510796e-03 | 2.600 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.538726e-03 | 2.595 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.577085e-03 | 2.589 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.577085e-03 | 2.589 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.626126e-03 | 2.581 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.657393e-03 | 2.576 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.657393e-03 | 2.576 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.739014e-03 | 2.562 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.848956e-03 | 2.545 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.995938e-03 | 2.523 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.995938e-03 | 2.523 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.133507e-03 | 2.504 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.168701e-03 | 2.499 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.915561e-03 | 2.535 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.214320e-03 | 2.493 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.490733e-03 | 2.457 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.490733e-03 | 2.457 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.618261e-03 | 2.442 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.648217e-03 | 2.438 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.741078e-03 | 2.427 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.579382e-03 | 2.339 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.610645e-03 | 2.336 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.302782e-03 | 2.366 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.302782e-03 | 2.366 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.700203e-03 | 2.328 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.302782e-03 | 2.366 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.700203e-03 | 2.328 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.354880e-03 | 2.361 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.380881e-03 | 2.358 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.345275e-03 | 2.362 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.360773e-03 | 2.360 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.812556e-03 | 2.318 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.883491e-03 | 2.311 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.119627e-03 | 2.291 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.492874e-03 | 2.260 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 5.694595e-03 | 2.245 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.058145e-03 | 2.218 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.133094e-03 | 2.212 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.340901e-03 | 2.198 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.897633e-03 | 2.161 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.283610e-03 | 2.138 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.295463e-03 | 2.081 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 8.383983e-03 | 2.077 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 8.383983e-03 | 2.077 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 8.383983e-03 | 2.077 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.383983e-03 | 2.077 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.815764e-03 | 2.107 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.571826e-03 | 2.121 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.571826e-03 | 2.121 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.072980e-03 | 2.093 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.899192e-03 | 2.102 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.815764e-03 | 2.107 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 7.912026e-03 | 2.102 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.815764e-03 | 2.107 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 8.383983e-03 | 2.077 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.740526e-03 | 2.058 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.758848e-03 | 2.058 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.015049e-03 | 2.045 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.015049e-03 | 2.045 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.057135e-02 | 1.976 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.057135e-02 | 1.976 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.057135e-02 | 1.976 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.057135e-02 | 1.976 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.057135e-02 | 1.976 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 9.864925e-03 | 2.006 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.728546e-03 | 2.012 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.025852e-02 | 1.989 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.018605e-02 | 1.992 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.821249e-03 | 2.008 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.458570e-03 | 2.024 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.864925e-03 | 2.006 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.000384e-02 | 2.000 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.864925e-03 | 2.006 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 9.864925e-03 | 2.006 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.020168e-02 | 1.991 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.059955e-02 | 1.975 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.090059e-02 | 1.963 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.093137e-02 | 1.961 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.093137e-02 | 1.961 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.112088e-02 | 1.954 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.134416e-02 | 1.945 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.160941e-02 | 1.935 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.165033e-02 | 1.934 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.166577e-02 | 1.933 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.174854e-02 | 1.930 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.179003e-02 | 1.928 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.184528e-02 | 1.926 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.184528e-02 | 1.926 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.184528e-02 | 1.926 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.185220e-02 | 1.926 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.196903e-02 | 1.922 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.202514e-02 | 1.920 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.285446e-02 | 1.891 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.292770e-02 | 1.888 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.295061e-02 | 1.888 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.295061e-02 | 1.888 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.298214e-02 | 1.887 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.298214e-02 | 1.887 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.298214e-02 | 1.887 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.306720e-02 | 1.884 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.384003e-02 | 1.859 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.435914e-02 | 1.843 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.519677e-02 | 1.818 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.361194e-02 | 1.866 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.495661e-02 | 1.825 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.550295e-02 | 1.810 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.588294e-02 | 1.799 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.616732e-02 | 1.791 | 0 | 0 |
| Translation | R-HSA-72766 | 1.659562e-02 | 1.780 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.665569e-02 | 1.778 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.711433e-02 | 1.767 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.778514e-02 | 1.750 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.930266e-02 | 1.714 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.949788e-02 | 1.710 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.018859e-02 | 1.695 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 2.092028e-02 | 1.679 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.092028e-02 | 1.679 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.103247e-02 | 1.677 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.103247e-02 | 1.677 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.103247e-02 | 1.677 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.103247e-02 | 1.677 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.133494e-02 | 1.671 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.139591e-02 | 1.670 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.139591e-02 | 1.670 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.139591e-02 | 1.670 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.139591e-02 | 1.670 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.139591e-02 | 1.670 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.139956e-02 | 1.670 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.142292e-02 | 1.669 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.142774e-02 | 1.669 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.142774e-02 | 1.669 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.211145e-02 | 1.655 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.211145e-02 | 1.655 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.211145e-02 | 1.655 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.670281e-02 | 1.573 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.769124e-02 | 1.558 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.769124e-02 | 1.558 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.678516e-02 | 1.572 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.365137e-02 | 1.626 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.612775e-02 | 1.583 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.769124e-02 | 1.558 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.612775e-02 | 1.583 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.436421e-02 | 1.613 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.769124e-02 | 1.558 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.801110e-02 | 1.553 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.884740e-02 | 1.540 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.888433e-02 | 1.539 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.019641e-02 | 1.520 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.034453e-02 | 1.518 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.115176e-02 | 1.507 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.115176e-02 | 1.507 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.259369e-02 | 1.487 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.500848e-02 | 1.456 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.500848e-02 | 1.456 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.500848e-02 | 1.456 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.500848e-02 | 1.456 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.512437e-02 | 1.454 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.512437e-02 | 1.454 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.590595e-02 | 1.445 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.590595e-02 | 1.445 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.630510e-02 | 1.440 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.754923e-02 | 1.425 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.795961e-02 | 1.421 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.841754e-02 | 1.415 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.841754e-02 | 1.415 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.841754e-02 | 1.415 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.862858e-02 | 1.413 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.447237e-02 | 1.352 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.447237e-02 | 1.352 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.447237e-02 | 1.352 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 4.672317e-02 | 1.330 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.341552e-02 | 1.362 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.609365e-02 | 1.336 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 4.314067e-02 | 1.365 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.585681e-02 | 1.339 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.991681e-02 | 1.399 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.419018e-02 | 1.355 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.419018e-02 | 1.355 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.841206e-02 | 1.315 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.672317e-02 | 1.330 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.052206e-02 | 1.392 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.965257e-02 | 1.402 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.672317e-02 | 1.330 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.991681e-02 | 1.399 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.477830e-02 | 1.349 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.486173e-02 | 1.348 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.991681e-02 | 1.399 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.585681e-02 | 1.339 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.585681e-02 | 1.339 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.541054e-02 | 1.343 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.358778e-02 | 1.361 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.609365e-02 | 1.336 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.341552e-02 | 1.362 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.140956e-02 | 1.383 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.877596e-02 | 1.312 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.934938e-02 | 1.307 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.125210e-02 | 1.290 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.293370e-02 | 1.276 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.293370e-02 | 1.276 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 5.293370e-02 | 1.276 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.351125e-02 | 1.272 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.351125e-02 | 1.272 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.357781e-02 | 1.271 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.439550e-02 | 1.264 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.439550e-02 | 1.264 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.439550e-02 | 1.264 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.487686e-02 | 1.261 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 5.487686e-02 | 1.261 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.618846e-02 | 1.250 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.738907e-02 | 1.241 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.830783e-02 | 1.234 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.837332e-02 | 1.234 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.837332e-02 | 1.234 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.837332e-02 | 1.234 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.846611e-02 | 1.233 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.888008e-02 | 1.230 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.888008e-02 | 1.230 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 5.888008e-02 | 1.230 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.894369e-02 | 1.230 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.894369e-02 | 1.230 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 5.915186e-02 | 1.228 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.915186e-02 | 1.228 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.915186e-02 | 1.228 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.915186e-02 | 1.228 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.130013e-02 | 1.213 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.130013e-02 | 1.213 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.130013e-02 | 1.213 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.144696e-02 | 1.211 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.145261e-02 | 1.211 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.145261e-02 | 1.211 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 7.409846e-02 | 1.130 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 7.409846e-02 | 1.130 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 7.409846e-02 | 1.130 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.531732e-02 | 1.123 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.354394e-02 | 1.133 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.587230e-02 | 1.181 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.703385e-02 | 1.113 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 7.029737e-02 | 1.153 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.402807e-02 | 1.076 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.402807e-02 | 1.076 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.990468e-02 | 1.155 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.990468e-02 | 1.155 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.283129e-02 | 1.138 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.006439e-02 | 1.155 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 6.587230e-02 | 1.181 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.006439e-02 | 1.155 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.008162e-02 | 1.096 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.014067e-02 | 1.154 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.356993e-02 | 1.197 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.691367e-02 | 1.114 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 8.063875e-02 | 1.093 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 8.171947e-02 | 1.088 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.613152e-02 | 1.180 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.605444e-02 | 1.119 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.354468e-02 | 1.197 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 6.326917e-02 | 1.199 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.393993e-02 | 1.131 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.356993e-02 | 1.197 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.354394e-02 | 1.133 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.587230e-02 | 1.181 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.193077e-02 | 1.143 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.316001e-02 | 1.136 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.354394e-02 | 1.133 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.393993e-02 | 1.131 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.356993e-02 | 1.197 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.356993e-02 | 1.197 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.605444e-02 | 1.119 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.605525e-02 | 1.180 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.356993e-02 | 1.197 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.484462e-02 | 1.188 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.356993e-02 | 1.197 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.249457e-02 | 1.140 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.408765e-02 | 1.075 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.408765e-02 | 1.075 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.408765e-02 | 1.075 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.408765e-02 | 1.075 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 8.438851e-02 | 1.074 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.438851e-02 | 1.074 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.438851e-02 | 1.074 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.438851e-02 | 1.074 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.438851e-02 | 1.074 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.438851e-02 | 1.074 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.445128e-02 | 1.073 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.445128e-02 | 1.073 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.815605e-02 | 1.055 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.815605e-02 | 1.055 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.815605e-02 | 1.055 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.815763e-02 | 1.055 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.869014e-02 | 1.052 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.869014e-02 | 1.052 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.869014e-02 | 1.052 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.994716e-02 | 1.046 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.178653e-02 | 1.037 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.236582e-02 | 1.034 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.260990e-02 | 1.033 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.311287e-02 | 1.031 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.606631e-02 | 1.017 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.717828e-02 | 1.012 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.915521e-02 | 1.004 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 1.000043e-01 | 1.000 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.007072e-01 | 0.997 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.015602e-01 | 0.993 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.015602e-01 | 0.993 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.019402e-01 | 0.992 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.020545e-01 | 0.991 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.020545e-01 | 0.991 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.020545e-01 | 0.991 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 1.020545e-01 | 0.991 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.022526e-01 | 0.990 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.022526e-01 | 0.990 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.022526e-01 | 0.990 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.022526e-01 | 0.990 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.024564e-01 | 0.989 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.026443e-01 | 0.989 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.026443e-01 | 0.989 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.034707e-01 | 0.985 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 1.053737e-01 | 0.977 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 1.053737e-01 | 0.977 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.053737e-01 | 0.977 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.053737e-01 | 0.977 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.056632e-01 | 0.976 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.056632e-01 | 0.976 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.056632e-01 | 0.976 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.060965e-01 | 0.974 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.072868e-01 | 0.969 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.072868e-01 | 0.969 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.072868e-01 | 0.969 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.078468e-01 | 0.967 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.078468e-01 | 0.967 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.085584e-01 | 0.964 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.085584e-01 | 0.964 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.085584e-01 | 0.964 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.093776e-01 | 0.961 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.093776e-01 | 0.961 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.093776e-01 | 0.961 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.110676e-01 | 0.954 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.111101e-01 | 0.954 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.111101e-01 | 0.954 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.111101e-01 | 0.954 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.113225e-01 | 0.953 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.113225e-01 | 0.953 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.113225e-01 | 0.953 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.118918e-01 | 0.951 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.118918e-01 | 0.951 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.118918e-01 | 0.951 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.118918e-01 | 0.951 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.130763e-01 | 0.947 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.169702e-01 | 0.932 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.169702e-01 | 0.932 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.447656e-01 | 0.839 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.447656e-01 | 0.839 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.258772e-01 | 0.900 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.512335e-01 | 0.820 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.512335e-01 | 0.820 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.642102e-01 | 0.785 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.218395e-01 | 0.914 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.496393e-01 | 0.825 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.227710e-01 | 0.911 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.660794e-01 | 0.780 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.660794e-01 | 0.780 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.461161e-01 | 0.835 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.246724e-01 | 0.904 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.382617e-01 | 0.859 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.294904e-01 | 0.888 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.670330e-01 | 0.777 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.649181e-01 | 0.783 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.762035e-01 | 0.754 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 1.490696e-01 | 0.827 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.338172e-01 | 0.873 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.672665e-01 | 0.777 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.657012e-01 | 0.781 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.670330e-01 | 0.777 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.374372e-01 | 0.862 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.419546e-01 | 0.848 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.423972e-01 | 0.846 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.315093e-01 | 0.881 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.239828e-01 | 0.907 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.642102e-01 | 0.785 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.642102e-01 | 0.785 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.714566e-01 | 0.766 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.315093e-01 | 0.881 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.435386e-01 | 0.843 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.642102e-01 | 0.785 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.339169e-01 | 0.873 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.506387e-01 | 0.822 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.358784e-01 | 0.867 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.232868e-01 | 0.909 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.232868e-01 | 0.909 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.280734e-01 | 0.893 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.227710e-01 | 0.911 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.714566e-01 | 0.766 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 1.714566e-01 | 0.766 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.628371e-01 | 0.788 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.206863e-01 | 0.918 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.626750e-01 | 0.789 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.206863e-01 | 0.918 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.220475e-01 | 0.913 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.496393e-01 | 0.825 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.256147e-01 | 0.901 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.209095e-01 | 0.918 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.658091e-01 | 0.780 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.670330e-01 | 0.777 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.620572e-01 | 0.790 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.190282e-01 | 0.924 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.206863e-01 | 0.918 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.771496e-01 | 0.752 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 1.585471e-01 | 0.800 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.594495e-01 | 0.797 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.637728e-01 | 0.786 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.637728e-01 | 0.786 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.670330e-01 | 0.777 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.537270e-01 | 0.813 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.585471e-01 | 0.800 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.490696e-01 | 0.827 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.229901e-01 | 0.910 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.673015e-01 | 0.777 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.628371e-01 | 0.788 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.771496e-01 | 0.752 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.315093e-01 | 0.881 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.423972e-01 | 0.846 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.642102e-01 | 0.785 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.490696e-01 | 0.827 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.660794e-01 | 0.780 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.672665e-01 | 0.777 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.771868e-01 | 0.752 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 1.780382e-01 | 0.749 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.780382e-01 | 0.749 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 1.780382e-01 | 0.749 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.780382e-01 | 0.749 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.791947e-01 | 0.747 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.805923e-01 | 0.743 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.818825e-01 | 0.740 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.821554e-01 | 0.740 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.821554e-01 | 0.740 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.821554e-01 | 0.740 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.821554e-01 | 0.740 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.838128e-01 | 0.736 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.838128e-01 | 0.736 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.838128e-01 | 0.736 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.848213e-01 | 0.733 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 1.848213e-01 | 0.733 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.856617e-01 | 0.731 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.856617e-01 | 0.731 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.856617e-01 | 0.731 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.858701e-01 | 0.731 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.858701e-01 | 0.731 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.858701e-01 | 0.731 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.858701e-01 | 0.731 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.876299e-01 | 0.727 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.876299e-01 | 0.727 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.901736e-01 | 0.721 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.902092e-01 | 0.721 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.902092e-01 | 0.721 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.902092e-01 | 0.721 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.908945e-01 | 0.719 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.919742e-01 | 0.717 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.919742e-01 | 0.717 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.996493e-01 | 0.700 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.996493e-01 | 0.700 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.996493e-01 | 0.700 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.996493e-01 | 0.700 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.996493e-01 | 0.700 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.996493e-01 | 0.700 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.996493e-01 | 0.700 | 0 | 0 |
| Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1) | R-HSA-5619043 | 1.996493e-01 | 0.700 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.996493e-01 | 0.700 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.839951e-01 | 0.547 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.839951e-01 | 0.547 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.839951e-01 | 0.547 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.839951e-01 | 0.547 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.839951e-01 | 0.547 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.839951e-01 | 0.547 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.839951e-01 | 0.547 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.839951e-01 | 0.547 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.839951e-01 | 0.547 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.839951e-01 | 0.547 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.241306e-01 | 0.649 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.241306e-01 | 0.649 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.241306e-01 | 0.649 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.241306e-01 | 0.649 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.594565e-01 | 0.444 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.594565e-01 | 0.444 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.594565e-01 | 0.444 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.594565e-01 | 0.444 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.594565e-01 | 0.444 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.594565e-01 | 0.444 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.650181e-01 | 0.577 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.650181e-01 | 0.577 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.348876e-01 | 0.629 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.059079e-01 | 0.514 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.059079e-01 | 0.514 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.083871e-01 | 0.681 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.083871e-01 | 0.681 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 2.083871e-01 | 0.681 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.083871e-01 | 0.681 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.644095e-01 | 0.578 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 2.644095e-01 | 0.578 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.316281e-01 | 0.635 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.463458e-01 | 0.460 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.463458e-01 | 0.460 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.463458e-01 | 0.460 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 2.047493e-01 | 0.689 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.943417e-01 | 0.531 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.554610e-01 | 0.593 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.554610e-01 | 0.593 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.554610e-01 | 0.593 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.160170e-01 | 0.666 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.160170e-01 | 0.666 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.797562e-01 | 0.553 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 3.244672e-01 | 0.489 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.859731e-01 | 0.413 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 3.859731e-01 | 0.413 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.336984e-01 | 0.631 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.545892e-01 | 0.450 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 3.545892e-01 | 0.450 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.556618e-01 | 0.592 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.077806e-01 | 0.512 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.077806e-01 | 0.512 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.845316e-01 | 0.415 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.845316e-01 | 0.415 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.845316e-01 | 0.415 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.724850e-01 | 0.565 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.724850e-01 | 0.565 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.724850e-01 | 0.565 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.439425e-01 | 0.613 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.439425e-01 | 0.613 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.081461e-01 | 0.511 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.510469e-01 | 0.455 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.791363e-01 | 0.421 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.791363e-01 | 0.421 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.468240e-01 | 0.460 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.728148e-01 | 0.429 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 2.541235e-01 | 0.595 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 3.564732e-01 | 0.448 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.180436e-01 | 0.498 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.053144e-01 | 0.515 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.310115e-01 | 0.480 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.835732e-01 | 0.416 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.315962e-01 | 0.635 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.724850e-01 | 0.565 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 2.730526e-01 | 0.564 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.202962e-01 | 0.657 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.988183e-01 | 0.702 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.702895e-01 | 0.568 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.702895e-01 | 0.568 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.274097e-01 | 0.485 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.778254e-01 | 0.423 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.047493e-01 | 0.689 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.859731e-01 | 0.413 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.423047e-01 | 0.616 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.209753e-01 | 0.494 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.423047e-01 | 0.616 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.728148e-01 | 0.429 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.059079e-01 | 0.514 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.083871e-01 | 0.681 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.372998e-01 | 0.472 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.946459e-01 | 0.711 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.320737e-01 | 0.634 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 2.644095e-01 | 0.578 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.653720e-01 | 0.576 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.556618e-01 | 0.592 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.996493e-01 | 0.700 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 2.348876e-01 | 0.629 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.083871e-01 | 0.681 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.463458e-01 | 0.460 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.463458e-01 | 0.460 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.988183e-01 | 0.702 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.890876e-01 | 0.539 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.728148e-01 | 0.429 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.995357e-01 | 0.700 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.524383e-01 | 0.453 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.510469e-01 | 0.455 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.702895e-01 | 0.568 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.510049e-01 | 0.455 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.510469e-01 | 0.455 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.468240e-01 | 0.460 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.864304e-01 | 0.543 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.845316e-01 | 0.415 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.631831e-01 | 0.440 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.730526e-01 | 0.564 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.872634e-01 | 0.542 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.275650e-01 | 0.485 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.557233e-01 | 0.592 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.275650e-01 | 0.485 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.783099e-01 | 0.422 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.218110e-01 | 0.654 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.554610e-01 | 0.593 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.797562e-01 | 0.553 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.545892e-01 | 0.450 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.545892e-01 | 0.450 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.128140e-01 | 0.672 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.292368e-01 | 0.482 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.423047e-01 | 0.616 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.077334e-01 | 0.512 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.960231e-01 | 0.708 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.797562e-01 | 0.553 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.128140e-01 | 0.672 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.851994e-01 | 0.545 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.992015e-01 | 0.701 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.069258e-01 | 0.513 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.423047e-01 | 0.616 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.996493e-01 | 0.700 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.996493e-01 | 0.700 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.839951e-01 | 0.547 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.594565e-01 | 0.444 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.594565e-01 | 0.444 | 0 | 0 |
| Antagonism of Activin by Follistatin | R-HSA-2473224 | 3.594565e-01 | 0.444 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.060125e-01 | 0.686 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 2.644095e-01 | 0.578 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.554610e-01 | 0.593 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.988183e-01 | 0.702 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 2.072756e-01 | 0.683 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.230167e-01 | 0.652 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.423047e-01 | 0.616 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.314823e-01 | 0.635 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.081461e-01 | 0.511 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.435686e-01 | 0.613 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.445514e-01 | 0.612 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.244672e-01 | 0.489 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 2.702895e-01 | 0.568 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.558555e-01 | 0.449 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.980675e-01 | 0.703 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.226395e-01 | 0.491 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.797562e-01 | 0.553 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.336984e-01 | 0.631 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.608755e-01 | 0.584 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.859731e-01 | 0.413 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.702895e-01 | 0.568 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.077806e-01 | 0.512 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.227870e-01 | 0.491 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.824921e-01 | 0.549 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.298993e-01 | 0.482 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.702895e-01 | 0.568 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.656698e-01 | 0.576 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.859731e-01 | 0.413 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 2.164203e-01 | 0.665 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.077806e-01 | 0.512 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.069258e-01 | 0.513 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.069258e-01 | 0.513 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.372998e-01 | 0.472 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.081461e-01 | 0.511 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.329833e-01 | 0.478 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.631831e-01 | 0.440 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.241306e-01 | 0.649 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.650181e-01 | 0.577 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.797562e-01 | 0.553 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.859731e-01 | 0.413 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.545892e-01 | 0.450 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.292368e-01 | 0.482 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.292368e-01 | 0.482 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.845316e-01 | 0.415 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 2.314823e-01 | 0.635 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.856665e-01 | 0.544 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.858942e-01 | 0.414 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.463458e-01 | 0.460 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.698071e-01 | 0.569 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 3.786887e-01 | 0.422 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.463458e-01 | 0.460 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.864304e-01 | 0.543 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.702895e-01 | 0.568 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.556618e-01 | 0.592 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.446851e-01 | 0.611 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.446851e-01 | 0.611 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.518078e-01 | 0.599 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.069258e-01 | 0.513 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.594565e-01 | 0.444 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.059079e-01 | 0.514 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.463458e-01 | 0.460 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.093080e-01 | 0.510 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.205861e-01 | 0.656 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.091412e-01 | 0.680 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.077806e-01 | 0.512 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.059079e-01 | 0.514 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.083871e-01 | 0.681 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.463458e-01 | 0.460 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.859731e-01 | 0.413 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.541884e-01 | 0.451 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.322761e-01 | 0.479 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.446190e-01 | 0.463 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.778254e-01 | 0.423 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.778254e-01 | 0.423 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.864304e-01 | 0.543 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 2.583383e-01 | 0.588 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 3.421484e-01 | 0.466 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.943417e-01 | 0.531 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.859731e-01 | 0.413 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.071440e-01 | 0.684 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.244672e-01 | 0.489 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.541884e-01 | 0.451 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.944465e-01 | 0.711 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.895869e-01 | 0.538 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.443049e-01 | 0.463 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.942412e-01 | 0.404 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.945793e-01 | 0.404 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.957353e-01 | 0.403 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.957353e-01 | 0.403 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.968636e-01 | 0.401 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.979389e-01 | 0.400 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.979389e-01 | 0.400 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.994964e-01 | 0.398 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.034925e-01 | 0.394 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.039816e-01 | 0.394 | 1 | 1 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.039816e-01 | 0.394 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.039816e-01 | 0.394 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.054493e-01 | 0.392 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 4.101823e-01 | 0.387 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.136423e-01 | 0.383 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.141391e-01 | 0.383 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.141391e-01 | 0.383 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.141391e-01 | 0.383 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.141391e-01 | 0.383 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 4.141391e-01 | 0.383 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.141659e-01 | 0.383 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.201094e-01 | 0.377 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.245117e-01 | 0.372 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.245117e-01 | 0.372 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.245117e-01 | 0.372 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.247901e-01 | 0.372 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.249538e-01 | 0.372 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.269687e-01 | 0.370 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.269687e-01 | 0.370 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.269687e-01 | 0.370 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.269687e-01 | 0.370 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 4.269687e-01 | 0.370 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.269687e-01 | 0.370 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.269687e-01 | 0.370 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.269687e-01 | 0.370 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.269687e-01 | 0.370 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.269687e-01 | 0.370 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.269687e-01 | 0.370 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.286331e-01 | 0.368 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.286331e-01 | 0.368 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.286331e-01 | 0.368 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.315099e-01 | 0.365 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.315099e-01 | 0.365 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.330745e-01 | 0.363 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.354033e-01 | 0.361 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.368434e-01 | 0.360 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.397155e-01 | 0.357 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.397155e-01 | 0.357 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.397155e-01 | 0.357 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.432760e-01 | 0.353 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.432760e-01 | 0.353 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.493036e-01 | 0.347 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.500288e-01 | 0.347 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.530081e-01 | 0.344 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.530081e-01 | 0.344 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.580584e-01 | 0.339 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.591223e-01 | 0.338 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.592184e-01 | 0.338 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.592184e-01 | 0.338 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.609784e-01 | 0.336 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.614294e-01 | 0.336 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.617510e-01 | 0.336 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.617510e-01 | 0.336 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.617510e-01 | 0.336 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 4.617510e-01 | 0.336 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.617510e-01 | 0.336 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.634361e-01 | 0.334 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.700961e-01 | 0.328 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 4.706473e-01 | 0.327 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.718254e-01 | 0.326 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.718254e-01 | 0.326 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.718254e-01 | 0.326 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.718254e-01 | 0.326 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.718523e-01 | 0.326 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.770318e-01 | 0.321 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.770318e-01 | 0.321 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.803563e-01 | 0.318 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.803563e-01 | 0.318 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.803563e-01 | 0.318 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.803563e-01 | 0.318 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.803563e-01 | 0.318 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 4.803563e-01 | 0.318 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.803563e-01 | 0.318 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.827277e-01 | 0.316 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.873689e-01 | 0.312 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.873689e-01 | 0.312 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.873689e-01 | 0.312 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.873689e-01 | 0.312 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.873689e-01 | 0.312 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.873689e-01 | 0.312 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.873689e-01 | 0.312 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.873689e-01 | 0.312 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.873689e-01 | 0.312 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.873689e-01 | 0.312 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.873689e-01 | 0.312 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.911470e-01 | 0.309 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.917060e-01 | 0.308 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.975369e-01 | 0.303 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.975369e-01 | 0.303 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.975369e-01 | 0.303 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.975369e-01 | 0.303 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.975369e-01 | 0.303 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.975369e-01 | 0.303 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.996888e-01 | 0.301 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 4.996888e-01 | 0.301 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 4.996888e-01 | 0.301 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 4.996888e-01 | 0.301 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.996888e-01 | 0.301 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 4.996888e-01 | 0.301 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.006375e-01 | 0.300 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.006375e-01 | 0.300 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.006375e-01 | 0.300 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.012056e-01 | 0.300 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.016065e-01 | 0.300 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.016065e-01 | 0.300 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 5.027811e-01 | 0.299 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.033882e-01 | 0.298 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.150091e-01 | 0.288 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.155996e-01 | 0.288 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.168896e-01 | 0.287 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.168896e-01 | 0.287 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.182097e-01 | 0.285 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.202363e-01 | 0.284 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.217223e-01 | 0.283 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.217223e-01 | 0.283 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.227346e-01 | 0.282 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 5.237667e-01 | 0.281 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.237667e-01 | 0.281 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.237667e-01 | 0.281 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.237667e-01 | 0.281 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.267839e-01 | 0.278 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.267839e-01 | 0.278 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.267839e-01 | 0.278 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.267839e-01 | 0.278 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.267839e-01 | 0.278 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.267839e-01 | 0.278 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.267839e-01 | 0.278 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.288826e-01 | 0.277 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.317620e-01 | 0.274 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.317620e-01 | 0.274 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.317620e-01 | 0.274 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.317620e-01 | 0.274 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.317620e-01 | 0.274 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.317620e-01 | 0.274 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.317620e-01 | 0.274 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.317620e-01 | 0.274 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.317620e-01 | 0.274 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.385856e-01 | 0.269 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.414057e-01 | 0.266 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.414057e-01 | 0.266 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.414057e-01 | 0.266 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.414057e-01 | 0.266 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.414057e-01 | 0.266 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.414057e-01 | 0.266 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.414057e-01 | 0.266 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.414057e-01 | 0.266 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.414057e-01 | 0.266 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.414057e-01 | 0.266 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.414057e-01 | 0.266 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.414057e-01 | 0.266 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.414057e-01 | 0.266 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.414057e-01 | 0.266 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.414057e-01 | 0.266 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.414057e-01 | 0.266 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.414057e-01 | 0.266 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.414057e-01 | 0.266 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.414057e-01 | 0.266 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.414057e-01 | 0.266 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.414057e-01 | 0.266 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.463681e-01 | 0.263 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 5.471864e-01 | 0.262 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.497119e-01 | 0.260 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.512397e-01 | 0.259 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 5.530440e-01 | 0.257 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 5.530440e-01 | 0.257 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 5.530440e-01 | 0.257 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.530440e-01 | 0.257 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.589248e-01 | 0.253 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 5.616048e-01 | 0.251 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.616048e-01 | 0.251 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.617676e-01 | 0.250 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.643579e-01 | 0.248 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.643579e-01 | 0.248 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.643579e-01 | 0.248 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.643579e-01 | 0.248 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.643579e-01 | 0.248 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.643579e-01 | 0.248 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.664223e-01 | 0.247 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.669347e-01 | 0.246 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.683982e-01 | 0.245 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.683982e-01 | 0.245 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.692357e-01 | 0.245 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.708152e-01 | 0.244 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.716821e-01 | 0.243 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.765725e-01 | 0.239 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.766017e-01 | 0.239 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.784163e-01 | 0.238 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.806433e-01 | 0.236 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.809043e-01 | 0.236 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.883978e-01 | 0.230 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.897494e-01 | 0.229 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.897494e-01 | 0.229 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.897494e-01 | 0.229 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.897494e-01 | 0.229 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.897494e-01 | 0.229 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.897494e-01 | 0.229 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.897494e-01 | 0.229 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.897494e-01 | 0.229 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.897494e-01 | 0.229 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.897494e-01 | 0.229 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.897494e-01 | 0.229 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.897494e-01 | 0.229 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.897494e-01 | 0.229 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.898200e-01 | 0.229 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.916778e-01 | 0.228 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 5.952876e-01 | 0.225 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.952876e-01 | 0.225 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.952876e-01 | 0.225 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.952876e-01 | 0.225 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.994221e-01 | 0.222 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.028611e-01 | 0.220 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.028611e-01 | 0.220 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.028611e-01 | 0.220 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.028611e-01 | 0.220 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.028611e-01 | 0.220 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.028611e-01 | 0.220 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.031981e-01 | 0.220 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.086461e-01 | 0.216 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.099550e-01 | 0.215 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.099550e-01 | 0.215 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.180856e-01 | 0.209 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.190269e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.190269e-01 | 0.208 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.203849e-01 | 0.207 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.245403e-01 | 0.204 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.245403e-01 | 0.204 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.245403e-01 | 0.204 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.263496e-01 | 0.203 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.263496e-01 | 0.203 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.263496e-01 | 0.203 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.307241e-01 | 0.200 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.307241e-01 | 0.200 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.307241e-01 | 0.200 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.319995e-01 | 0.199 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.319995e-01 | 0.199 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.319995e-01 | 0.199 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.319995e-01 | 0.199 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.319995e-01 | 0.199 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.329993e-01 | 0.199 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.329993e-01 | 0.199 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.329993e-01 | 0.199 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.329993e-01 | 0.199 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.329993e-01 | 0.199 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.329993e-01 | 0.199 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.329993e-01 | 0.199 | 0 | 0 |
| Lactose synthesis | R-HSA-5653890 | 6.329993e-01 | 0.199 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.329993e-01 | 0.199 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.329993e-01 | 0.199 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.329993e-01 | 0.199 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.329993e-01 | 0.199 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.329993e-01 | 0.199 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.330111e-01 | 0.199 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.341903e-01 | 0.198 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.359254e-01 | 0.197 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.443683e-01 | 0.191 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.468545e-01 | 0.189 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.468545e-01 | 0.189 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.488637e-01 | 0.188 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.488637e-01 | 0.188 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.488637e-01 | 0.188 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.488637e-01 | 0.188 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.488637e-01 | 0.188 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.501347e-01 | 0.187 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.501640e-01 | 0.187 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.503622e-01 | 0.187 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.511760e-01 | 0.186 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.511760e-01 | 0.186 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.521257e-01 | 0.186 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.521257e-01 | 0.186 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.521257e-01 | 0.186 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.521257e-01 | 0.186 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.571137e-01 | 0.182 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.571137e-01 | 0.182 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.575360e-01 | 0.182 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.613510e-01 | 0.180 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.626791e-01 | 0.179 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.667624e-01 | 0.176 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.681585e-01 | 0.175 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.686998e-01 | 0.175 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.687883e-01 | 0.175 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.689097e-01 | 0.175 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.689097e-01 | 0.175 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.700248e-01 | 0.174 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.703940e-01 | 0.174 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.703940e-01 | 0.174 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.703940e-01 | 0.174 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.703940e-01 | 0.174 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.703940e-01 | 0.174 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.703940e-01 | 0.174 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.703940e-01 | 0.174 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.716920e-01 | 0.173 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.716920e-01 | 0.173 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.716920e-01 | 0.173 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.716920e-01 | 0.173 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.716920e-01 | 0.173 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.716920e-01 | 0.173 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.716920e-01 | 0.173 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.716920e-01 | 0.173 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 6.716920e-01 | 0.173 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.716920e-01 | 0.173 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.716920e-01 | 0.173 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.716920e-01 | 0.173 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.716920e-01 | 0.173 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.719015e-01 | 0.173 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.719015e-01 | 0.173 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.719015e-01 | 0.173 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.780703e-01 | 0.169 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.780703e-01 | 0.169 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.780703e-01 | 0.169 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.780703e-01 | 0.169 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.833138e-01 | 0.165 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.862632e-01 | 0.164 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.862632e-01 | 0.164 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.862632e-01 | 0.164 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.892342e-01 | 0.162 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.900898e-01 | 0.161 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.909392e-01 | 0.161 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.909392e-01 | 0.161 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.976540e-01 | 0.156 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.977300e-01 | 0.156 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.999916e-01 | 0.155 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.016776e-01 | 0.154 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.024133e-01 | 0.153 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.024133e-01 | 0.153 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.024133e-01 | 0.153 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.024133e-01 | 0.153 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.026076e-01 | 0.153 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.030158e-01 | 0.153 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.042351e-01 | 0.152 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.042351e-01 | 0.152 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.042894e-01 | 0.152 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.063073e-01 | 0.151 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.063073e-01 | 0.151 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 7.063073e-01 | 0.151 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.063073e-01 | 0.151 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.063073e-01 | 0.151 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.063073e-01 | 0.151 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 7.063073e-01 | 0.151 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.063073e-01 | 0.151 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.063073e-01 | 0.151 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.063073e-01 | 0.151 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.063073e-01 | 0.151 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.063073e-01 | 0.151 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.063073e-01 | 0.151 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.063073e-01 | 0.151 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.063073e-01 | 0.151 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.105045e-01 | 0.148 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.105045e-01 | 0.148 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.170862e-01 | 0.144 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.170862e-01 | 0.144 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 7.170862e-01 | 0.144 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.170862e-01 | 0.144 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.183192e-01 | 0.144 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.208006e-01 | 0.142 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 7.252040e-01 | 0.140 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.252040e-01 | 0.140 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.252040e-01 | 0.140 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.252040e-01 | 0.140 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.252040e-01 | 0.140 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.252040e-01 | 0.140 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.291015e-01 | 0.137 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.291015e-01 | 0.137 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.291015e-01 | 0.137 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.291015e-01 | 0.137 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.291015e-01 | 0.137 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.291015e-01 | 0.137 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 7.291239e-01 | 0.137 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.291261e-01 | 0.137 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.368461e-01 | 0.133 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.368461e-01 | 0.133 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.372748e-01 | 0.132 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.372748e-01 | 0.132 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.372748e-01 | 0.132 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.372748e-01 | 0.132 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.372748e-01 | 0.132 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.372748e-01 | 0.132 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.372748e-01 | 0.132 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.372748e-01 | 0.132 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.372748e-01 | 0.132 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.372748e-01 | 0.132 | 1 | 1 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.372748e-01 | 0.132 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.372748e-01 | 0.132 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.383947e-01 | 0.132 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.398139e-01 | 0.131 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.456934e-01 | 0.127 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.464990e-01 | 0.127 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.464990e-01 | 0.127 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.467463e-01 | 0.127 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.467463e-01 | 0.127 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.467463e-01 | 0.127 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.510781e-01 | 0.124 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.520761e-01 | 0.124 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.532289e-01 | 0.123 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 7.535988e-01 | 0.123 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 7.535988e-01 | 0.123 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.547458e-01 | 0.122 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.634595e-01 | 0.117 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.634595e-01 | 0.117 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.634595e-01 | 0.117 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.636573e-01 | 0.117 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.636573e-01 | 0.117 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.649786e-01 | 0.116 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.649786e-01 | 0.116 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.649786e-01 | 0.116 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.649786e-01 | 0.116 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.649786e-01 | 0.116 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.649786e-01 | 0.116 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.649786e-01 | 0.116 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.649786e-01 | 0.116 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.649786e-01 | 0.116 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 7.649786e-01 | 0.116 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.663603e-01 | 0.116 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.663603e-01 | 0.116 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.663603e-01 | 0.116 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.663603e-01 | 0.116 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.663603e-01 | 0.116 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.666186e-01 | 0.115 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.668726e-01 | 0.115 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.702438e-01 | 0.113 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.721033e-01 | 0.112 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.747000e-01 | 0.111 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.792650e-01 | 0.108 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.804854e-01 | 0.108 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 7.844983e-01 | 0.105 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.848535e-01 | 0.105 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.848535e-01 | 0.105 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.848535e-01 | 0.105 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.848535e-01 | 0.105 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.848535e-01 | 0.105 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.853575e-01 | 0.105 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.897626e-01 | 0.103 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.897626e-01 | 0.103 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.897626e-01 | 0.103 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.897626e-01 | 0.103 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.897626e-01 | 0.103 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.897626e-01 | 0.103 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.897626e-01 | 0.103 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.897626e-01 | 0.103 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.897626e-01 | 0.103 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.897626e-01 | 0.103 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.897626e-01 | 0.103 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.897776e-01 | 0.102 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.897776e-01 | 0.102 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 7.922426e-01 | 0.101 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.941896e-01 | 0.100 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.941896e-01 | 0.100 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.979978e-01 | 0.098 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 8.006533e-01 | 0.097 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.020461e-01 | 0.096 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.020461e-01 | 0.096 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.020461e-01 | 0.096 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 8.020461e-01 | 0.096 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.020461e-01 | 0.096 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.062483e-01 | 0.094 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.062483e-01 | 0.094 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.062483e-01 | 0.094 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 8.082622e-01 | 0.092 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.082622e-01 | 0.092 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.109214e-01 | 0.091 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.119343e-01 | 0.090 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.119343e-01 | 0.090 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.119343e-01 | 0.090 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.119343e-01 | 0.090 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.119343e-01 | 0.090 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 8.119343e-01 | 0.090 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.119343e-01 | 0.090 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.119343e-01 | 0.090 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.180068e-01 | 0.087 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 8.180068e-01 | 0.087 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.180068e-01 | 0.087 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.215136e-01 | 0.085 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.244978e-01 | 0.084 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.245613e-01 | 0.084 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.293024e-01 | 0.081 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.294941e-01 | 0.081 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.317690e-01 | 0.080 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.317690e-01 | 0.080 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.317690e-01 | 0.080 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.317690e-01 | 0.080 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.317690e-01 | 0.080 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.317690e-01 | 0.080 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.317690e-01 | 0.080 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.317690e-01 | 0.080 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.317690e-01 | 0.080 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.317690e-01 | 0.080 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.317690e-01 | 0.080 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.317690e-01 | 0.080 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.317690e-01 | 0.080 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.328040e-01 | 0.079 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.328040e-01 | 0.079 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.330205e-01 | 0.079 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.339755e-01 | 0.079 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.339755e-01 | 0.079 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.339755e-01 | 0.079 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.339755e-01 | 0.079 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.387438e-01 | 0.076 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.394640e-01 | 0.076 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.441234e-01 | 0.074 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.456805e-01 | 0.073 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.456805e-01 | 0.073 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.456805e-01 | 0.073 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.465056e-01 | 0.072 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.465056e-01 | 0.072 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.465056e-01 | 0.072 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.475045e-01 | 0.072 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.481288e-01 | 0.072 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 8.481676e-01 | 0.072 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.495128e-01 | 0.071 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.495128e-01 | 0.071 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.495128e-01 | 0.071 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.495128e-01 | 0.071 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 8.495128e-01 | 0.071 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.495128e-01 | 0.071 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 8.495128e-01 | 0.071 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.495128e-01 | 0.071 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.495128e-01 | 0.071 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.495128e-01 | 0.071 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.503714e-01 | 0.070 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.546037e-01 | 0.068 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.591781e-01 | 0.066 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.591781e-01 | 0.066 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.591781e-01 | 0.066 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.599718e-01 | 0.066 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.653860e-01 | 0.063 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.653860e-01 | 0.063 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.653860e-01 | 0.063 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.653860e-01 | 0.063 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.653860e-01 | 0.063 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.653860e-01 | 0.063 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.653860e-01 | 0.063 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.653860e-01 | 0.063 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.653860e-01 | 0.063 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.653860e-01 | 0.063 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.653860e-01 | 0.063 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.655416e-01 | 0.063 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.655416e-01 | 0.063 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.669529e-01 | 0.062 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.690410e-01 | 0.061 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.708861e-01 | 0.060 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.708861e-01 | 0.060 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.724824e-01 | 0.059 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.734206e-01 | 0.059 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.749659e-01 | 0.058 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.791995e-01 | 0.056 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.795858e-01 | 0.056 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.795858e-01 | 0.056 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.795858e-01 | 0.056 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.795858e-01 | 0.056 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.795858e-01 | 0.056 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 8.795858e-01 | 0.056 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.795858e-01 | 0.056 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.795858e-01 | 0.056 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.795858e-01 | 0.056 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 8.795858e-01 | 0.056 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.795858e-01 | 0.056 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.816919e-01 | 0.055 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.816919e-01 | 0.055 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.816919e-01 | 0.055 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.816919e-01 | 0.055 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.816919e-01 | 0.055 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.816919e-01 | 0.055 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.816919e-01 | 0.055 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.855958e-01 | 0.053 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.856696e-01 | 0.053 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.860680e-01 | 0.053 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.884863e-01 | 0.051 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.912412e-01 | 0.050 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.916556e-01 | 0.050 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.916556e-01 | 0.050 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.922884e-01 | 0.049 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.922884e-01 | 0.049 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.922884e-01 | 0.049 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.922884e-01 | 0.049 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.922884e-01 | 0.049 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.922884e-01 | 0.049 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.932712e-01 | 0.049 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.940129e-01 | 0.049 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.940129e-01 | 0.049 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.940129e-01 | 0.049 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.940129e-01 | 0.049 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.940129e-01 | 0.049 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.940129e-01 | 0.049 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.971807e-01 | 0.047 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.971807e-01 | 0.047 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.988137e-01 | 0.046 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.990401e-01 | 0.046 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.004254e-01 | 0.046 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.004254e-01 | 0.046 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.008346e-01 | 0.045 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.008346e-01 | 0.045 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.008346e-01 | 0.045 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 9.008346e-01 | 0.045 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.008346e-01 | 0.045 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.018693e-01 | 0.045 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.036517e-01 | 0.044 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 9.036517e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.036517e-01 | 0.044 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.036517e-01 | 0.044 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 9.036517e-01 | 0.044 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.036517e-01 | 0.044 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.036517e-01 | 0.044 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.043106e-01 | 0.044 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.074105e-01 | 0.042 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.091960e-01 | 0.041 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.091960e-01 | 0.041 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.091960e-01 | 0.041 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.091960e-01 | 0.041 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.091960e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.091960e-01 | 0.041 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.091960e-01 | 0.041 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.092835e-01 | 0.041 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.138168e-01 | 0.039 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.138168e-01 | 0.039 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.138168e-01 | 0.039 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.138168e-01 | 0.039 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.138168e-01 | 0.039 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.138168e-01 | 0.039 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.138168e-01 | 0.039 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 9.138168e-01 | 0.039 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.156311e-01 | 0.038 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.160227e-01 | 0.038 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.160227e-01 | 0.038 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.170541e-01 | 0.038 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.170541e-01 | 0.038 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.194079e-01 | 0.036 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.223784e-01 | 0.035 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.229100e-01 | 0.035 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.229100e-01 | 0.035 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.229100e-01 | 0.035 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.229100e-01 | 0.035 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.239444e-01 | 0.034 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.241955e-01 | 0.034 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.273657e-01 | 0.033 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.283136e-01 | 0.032 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.299595e-01 | 0.032 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.300669e-01 | 0.031 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.310443e-01 | 0.031 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.310443e-01 | 0.031 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.310443e-01 | 0.031 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.310443e-01 | 0.031 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.310443e-01 | 0.031 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.310443e-01 | 0.031 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.310443e-01 | 0.031 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.310443e-01 | 0.031 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.310443e-01 | 0.031 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.310443e-01 | 0.031 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.310443e-01 | 0.031 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.313690e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.337867e-01 | 0.030 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.337867e-01 | 0.030 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.338381e-01 | 0.030 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.341624e-01 | 0.030 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.350809e-01 | 0.029 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.350809e-01 | 0.029 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.355147e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.367728e-01 | 0.028 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.367728e-01 | 0.028 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.367728e-01 | 0.028 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.379597e-01 | 0.028 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.383206e-01 | 0.028 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.383206e-01 | 0.028 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.383206e-01 | 0.028 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.383206e-01 | 0.028 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 9.388917e-01 | 0.027 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.396563e-01 | 0.027 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.401130e-01 | 0.027 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.422929e-01 | 0.026 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.422929e-01 | 0.026 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.439360e-01 | 0.025 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.448296e-01 | 0.025 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.448296e-01 | 0.025 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.448296e-01 | 0.025 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.448296e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.448296e-01 | 0.025 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.448296e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.473526e-01 | 0.023 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.506520e-01 | 0.022 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.506520e-01 | 0.022 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.506520e-01 | 0.022 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.506520e-01 | 0.022 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.519875e-01 | 0.021 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.519875e-01 | 0.021 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.519875e-01 | 0.021 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.519875e-01 | 0.021 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.521001e-01 | 0.021 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.558602e-01 | 0.020 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.558602e-01 | 0.020 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.558602e-01 | 0.020 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.558602e-01 | 0.020 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.558602e-01 | 0.020 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.558602e-01 | 0.020 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.558602e-01 | 0.020 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.580404e-01 | 0.019 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.593692e-01 | 0.018 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.601136e-01 | 0.018 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.601136e-01 | 0.018 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.605190e-01 | 0.017 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.605190e-01 | 0.017 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.605190e-01 | 0.017 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.605190e-01 | 0.017 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.605190e-01 | 0.017 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 9.605190e-01 | 0.017 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.605190e-01 | 0.017 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.614941e-01 | 0.017 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.619812e-01 | 0.017 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.634070e-01 | 0.016 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.642828e-01 | 0.016 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.645447e-01 | 0.016 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.646864e-01 | 0.016 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.646864e-01 | 0.016 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.646864e-01 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.648492e-01 | 0.016 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.674552e-01 | 0.014 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.677469e-01 | 0.014 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.683562e-01 | 0.014 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.684141e-01 | 0.014 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.684141e-01 | 0.014 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.684141e-01 | 0.014 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.684141e-01 | 0.014 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.684141e-01 | 0.014 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.684141e-01 | 0.014 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.684141e-01 | 0.014 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.695556e-01 | 0.013 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.698767e-01 | 0.013 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.717485e-01 | 0.012 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.717485e-01 | 0.012 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.717485e-01 | 0.012 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.717485e-01 | 0.012 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.717485e-01 | 0.012 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.717485e-01 | 0.012 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.730230e-01 | 0.012 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.730230e-01 | 0.012 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.730230e-01 | 0.012 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.732069e-01 | 0.012 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.739456e-01 | 0.011 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.739456e-01 | 0.011 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.747310e-01 | 0.011 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.747310e-01 | 0.011 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.747310e-01 | 0.011 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.747310e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.747310e-01 | 0.011 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.748635e-01 | 0.011 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.773989e-01 | 0.010 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.773989e-01 | 0.010 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.775791e-01 | 0.010 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.775989e-01 | 0.010 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.779607e-01 | 0.010 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.793727e-01 | 0.009 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.797852e-01 | 0.009 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.810003e-01 | 0.008 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.819197e-01 | 0.008 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.825700e-01 | 0.008 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.838289e-01 | 0.007 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.839937e-01 | 0.007 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.849413e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.853231e-01 | 0.006 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.853451e-01 | 0.006 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.853465e-01 | 0.006 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.855366e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.855366e-01 | 0.006 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.859375e-01 | 0.006 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.859375e-01 | 0.006 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.861076e-01 | 0.006 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.870641e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.870641e-01 | 0.006 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.871877e-01 | 0.006 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.884063e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.884303e-01 | 0.005 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.884303e-01 | 0.005 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.888604e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.891987e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.896523e-01 | 0.005 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.896523e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.896523e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.905505e-01 | 0.004 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.907454e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.913359e-01 | 0.004 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.917047e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.925973e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.925973e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.925973e-01 | 0.003 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.925973e-01 | 0.003 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.925973e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.925973e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.926987e-01 | 0.003 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.927621e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.933794e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.933794e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.933794e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.934946e-01 | 0.003 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.938439e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.940789e-01 | 0.003 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.941415e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.947045e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.947045e-01 | 0.002 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.947045e-01 | 0.002 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.951882e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.951882e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.952589e-01 | 0.002 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.956403e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.957645e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.960507e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.961487e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.962121e-01 | 0.002 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.962324e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.966124e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.967608e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.969705e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.972754e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.972907e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.974025e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.975891e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.976065e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.978332e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.983157e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.983894e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.984503e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.985432e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.986142e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.986142e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.986629e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.986826e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.987819e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.988461e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.988689e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.989092e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.989537e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.990264e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.992075e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.992468e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.992508e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.994310e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.994538e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.994933e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.995469e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.995483e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.996377e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.996734e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.996760e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.996872e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997136e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997136e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997198e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997353e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997665e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.997684e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997684e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.998047e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.998157e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.998499e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998519e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998519e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.998519e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998519e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998572e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998816e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.998823e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998942e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998942e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998992e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999153e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999164e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999356e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999387e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999517e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999517e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999587e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999655e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999753e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999779e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999798e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999824e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999833e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999910e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999916e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999928e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999950e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999979e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999983e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999987e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999989e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999997e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |